Document

0000898770-18-000040.txt : 20181101 0000898770-18-000040.hdr.sgml : 20181101 20181101153003 ACCESSION NUMBER: 0000898770-18-000040 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181101 DATE AS OF CHANGE: 20181101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHARPS COMPLIANCE CORP CENTRAL INDEX KEY: 0000898770 STANDARD INDUSTRIAL CLASSIFICATION: HAZARDOUS WASTE MANAGEMENT [4955] IRS NUMBER: 742657168 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34269 FILM NUMBER: 181153462 BUSINESS ADDRESS: STREET 1: 9220 KIRBY DRIVE STREET 2: STE 500 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-432-0300 MAIL ADDRESS: STREET 1: 9220 KIRBY DRIVE STREET 2: STE 500 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: US MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19970128 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL POLYMERS TECHNOLOGIES INC DATE OF NAME CHANGE: 19930916 10-Q 1 q1fy1910q.htm 10-Q Q1 FY19 Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________

FORM 10-Q


ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018


¨	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Commission File Number: 001-34269

_______________________

SHARPS COMPLIANCE CORP.

(Exact name of registrant as specified in its charter)



Delaware	74-2657168
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)



9220 Kirby Drive, Suite 500, Houston, Texas	77054
(Address of principal executive offices)	(Zip Code)

(713) 432-0300

(Registrant’s telephone number, including area code)

Indicate by check mark if the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934.




Large Accelerated Filer o	Accelerated Filer o	Non-accelerated Filer o (Do not check if a smaller reporting company)	Emerging growth company o	Smaller reporting company ý

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act). Yes o No ý

As of October 30, 2018, there were 16,082,021 outstanding shares of the Registrant's common stock, par value $0.01 per share.



SHARPS COMPLIANCE CORP. AND SUBSIDIARIES


PART I	FINANCIAL INFORMATION	PAGE

Item 1.	Condensed Consolidated Financial Statements	3

	Condensed Consolidated Balance Sheets as of September 30, 2018 and June 30, 2018	3

	Condensed Consolidated Statements of Operations for the three months ended September 30, 2018 and 2017	4

	Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 30, 2018 and year ended June 30, 2018	5

	Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2018 and 2017	6

	Notes to Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 4.	Controls and Procedures	17

Part II	OTHER INFORMATION	17

Item 1.	Legal Proceedings	17

Item 1A.	Risk Factors	17

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	17

Item 6.	Exhibits	18

	SIGNATURES	18

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and par value)



	September 30,			June 30,
	2018			2018

ASSETS
CURRENT ASSETS
Cash	$	5,149		$	5,155
Accounts receivable, net of allowance for doubtful accounts of $110 and $102, respectively	6,800			6,370
Inventory	4,144			3,986
Contract asset	278			—
Prepaid and other current assets	741			739
TOTAL CURRENT ASSETS	17,112			16,250

PROPERTY, PLANT AND EQUIPMENT, net	6,310			6,572
LONG-TERM CONTRACT ASSET, net of current portion	60			—
OTHER ASSETS	143			149
GOODWILL	6,735			6,735
INTANGIBLE ASSETS, net	3,536			3,525
TOTAL ASSETS	$	33,896		$	33,231

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable	$	1,894		$	1,500
Accrued liabilities	2,042			2,061
Current maturities of long-term debt	517			537
Contract liability	1,801			1,894
TOTAL CURRENT LIABILITIES	6,254			5,992

LONG-TERM CONTRACT LIABILITY, net of current portion	462			470
OTHER LONG-TERM LIABILITIES	137			130
LONG-TERM DEFERRED TAX LIABILITY	25			—
LONG-TERM DEBT, net of current portion	1,335			1,465
TOTAL LIABILITIES	8,213			8,057

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,377,636 shares issued and 16,082,021 shares outstanding	164			164
Treasury stock, at cost, 295,615 shares repurchased	(1,554		)	(1,554		)
Additional paid-in capital	28,722			28,621
Accumulated deficit	(1,649		)	(2,057		)
TOTAL STOCKHOLDERS' EQUITY	25,683			25,174

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	33,896		$	33,231

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per-share data)



	Three-Months Ended September 30,
	2018			2017

REVENUES	$	10,293		$	9,683
Cost of revenues	6,941			6,655
GROSS PROFIT	3,352			3,028

Selling, general and administrative	3,026			2,725
Depreciation and amortization	201			202

OPERATING INCOME	125			101

OTHER INCOME (EXPENSE)
Interest income	5			5
Interest expense	(23		)	(24		)
TOTAL OTHER EXPENSE	(18		)	(19		)

INCOME BEFORE INCOME TAXES	107			82

INCOME TAX EXPENSE
Current	4			5
Deferred	33			2
TOTAL INCOME TAX EXPENSE	37			7

NET INCOME	$	70		$	75

NET INCOME PER COMMON SHARE - Basic and Diluted	$	0.00		$	0.00

WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE:
Basic	16,082			16,008
Diluted	16,089			16,093

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

(In thousands, except share data)



	Common Stock				Treasury Stock					Additional Paid-in Capital			Accumulated Deficit			Total Stockholders' Equity
	Shares		Amount		Shares		Amount			Additional Paid-in Capital			Accumulated Deficit			Total Stockholders' Equity

Balances, June 30, 2017		16,304,027	$	163	(295,615	)	$	(1,554	)	$	28,063		$	(1,385	)	$	25,287
Stock-based compensation		—	—		—		—			476			—			476
Issuance of common shares for lease		20,617	—		—		—			83			—			83
Issuance of restricted stock		52,992	1		—		—			(1		)	—			—
Net loss		—	—		—		—			—			(672		)	(672		)
Balances, June 30, 2018		16,377,636	164		(295,615	)	(1,554		)	28,621			(2,057		)	25,174
Stock-based compensation		—	—		—		—			101			—			101
Cumulative effect of new accounting standard (Note 3)		—	—		—		—			—			338			338
Net income		—	—		—		—			—			70			70
Balances, September 30, 2018		16,377,636	$	164	(295,615	)	$	(1,554	)	$	28,722		$	(1,649	)	$	25,683

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)



	Three-Months Ended September 30,
	2018			2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	70		$	75
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	391			390
Bad debt expense	17			5
Non-cash lease expense	12			—
Loss on disposal of property, plant and equipment	—			(2		)
Stock-based compensation expense	101			121
Deferred tax expense	33			2
Changes in operating assets and liabilities:
Accounts receivable	(447		)	269
Inventory	(39		)	(72		)
Prepaid and other assets	(16		)	124
Accounts payable and accrued liabilities	365			(29		)
Contract liability	(101		)	25
NET CASH PROVIDED BY OPERATING ACTIVITIES	386			908

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(79		)	(235		)
Cash proceeds from sale of property, plant and equipment	—			3
Additions to intangible assets	(163		)	(41		)
NET CASH USED IN INVESTING ACTIVITIES	(242		)	(273		)

CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of long-term debt	(150		)	(150		)
NET CASH USED IN FINANCING ACTIVITIES	(150		)	(150		)

NET (DECREASE) INCREASE IN CASH	(6		)	485

CASH, beginning of period	5,155			4,675

CASH, end of period	$	5,149		$	5,160

SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	$	8		$	3

Interest paid on long-term debt	$	24		$	17

NON-CASH INVESTING ACTIVITIES:

Transfer of equipment to inventory	$	119		$	69
Property, plant and equipment financed through accounts payable	$	17		$	21

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 - ORGANIZATION AND BACKGROUND

Organization: The accompanying unaudited condensed consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation.

Business: Sharps is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System^®), TakeAway Medication Recovery System™, MedSafe^®, TakeAway Recycle System™,ComplianceTRAC^SM, SharpsTracer^®, Sharps Secure^®Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System. The Company also offers its route-based pick-up services in a twenty-four (24) state region of the South, Southeast and Northeast portions of the United States.

NOTE 2 - BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under generally accepted accounting principles in the United States of America ("GAAP") for complete financial statements. Additionally, the preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of September 30, 2018, the results of its operations for the three months ended September 30, 2018 and 2017, cash flows for the three months ended September 30, 2018 and 2017 and stockholders’ equity for the three months ended September 30, 2018. The results of operations for the three months ended September 30, 2018 are not necessarily indicative of the results to be expected for the entire fiscal year ending June 30, 2019. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended June 30, 2018.

NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition: In May 2014 and as subsequently amended, guidance for revenue recognition was issued which supersedes the revenue recognition requirements previously followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a full retrospective approach or a modified retrospective approach to implement the standard. The Company adopted the standard on July 1, 2018 using the modified retrospective approach, which involves retrospectively adopting the standard by recording a cumulative effect adjustment for all uncompleted contracts at July 1, 2018. This cumulative effect was $0.3 million which decreased accumulated deficit (and increased stockholders' equity) and increased contract assets by $0.3 million. The impact that the new accounting guidance had on its consolidated financial statements and related disclosures included the following:


•	The transportation and treatment performance obligations related to the mail back and unused medication solutions, which were historically accounted for as separate performance obligations, will be accounted for as a single performance obligation under the new revenue recognition guidance. The impact of this was not material.


•	Certain costs associated with obtaining long-term contracts with customers will be capitalized and amortized over the expected economic life of the contract in future periods. The impact of this was not material.


•	The new guidance changed the timing of revenue recognition on certain of the Company’s vendor managed inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.


•	The Company made a number of practical expedient elections related to the new accounting guidance, including: (i) right to invoice practical expedient that allows revenue for route-based pickup services to be recognized in the amount to which the Company has a right to invoice over time; (ii) sales and use taxes have been excluded from the

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

transaction price; (iii) for incremental costs to obtain a contract that would be recognized over one year or less, the Company expenses those costs as incurred; and (iv) at the implementation date, new guidance was applied only to contracts that were not completed as of the date of initial application.

The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (in thousands):



	Three-Months Ended September 30,
	2018		% Total		2017⁽²⁾		% Total
REVENUES BY SOLUTION:
Mailbacks	$	5,607	54.5	%	$	5,465	56.4	%
Route-based pickup services	2,128		20.7	%	1,761		18.2	%
Unused medications	1,639		15.9	%	1,172		12.1	%
Third party treatment services	102		1.0	%	434		4.5	%
Other ⁽¹⁾	817		7.9	%	851		8.8	%
Total revenues	$	10,293	100.0	%	$	9,683	100.0	%


(1)	The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.


(2)	Certain prior year amounts have been reclassified to conform to current year presentation.

The Company recognizes revenue, net of applicable sales tax, when performance obligations are satisfied through the transfer of control of promised goods or services to the Company’s customers. Control transfers once a customer has the ability to direct the use of, and obtain substantially all of the benefits from, the promised goods or services. Outbound shipping and handling activities to customers are considered fulfillment activities with the exception of mailbacks sold as part of the vendor managed inventory ("VMI") program. Shipping and handling are considered separate performance obligations for mailbacks sold under the VMI program. For performance obligations satisfied at a point in time, which applies to all contract categories except for route-based pickup services, revenue recognition occurs when there is a transfer of control or completion of service. For performance obligations satisfied over time, which applies to the route-based pickup services contract category, revenue is recognized in the amount to which the Company has a right to invoice pursuant to the right to invoice practical expedient. Provisions for certain rebates, product returns and discounts to customers are estimated at the inception of the contract, updated as needed throughout the contract term, and accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served.

Other than the Company’s mailbacks and unused medication contract categories, the Company’s solutions have a single performance obligation. The Company's mailbacks and unused medication solutions have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the MedSafe and TakeAway Medication Recovery Systems referred to as “mailbacks” or "unused medications") and can consist of up to two performance obligations, or units of measure, as follows: (1) the sale of the compliance and container system, and (2) return transportation and treatment service. For mailbacks that are part of the VMI program, there is an additional element, or unit of measure, for outbound transportation. For contracts with multiple performance obligations, an estimated stand-alone selling price is determined for all performance obligations. The consideration is then allocated to the performance obligations based on their relative stand-alone selling price. The selling price for performance obligations for transportation and treatment utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including the expected cost plus a margin.

The allocated transaction price for the sale of the compliance and container system is recognized upon delivery to the customer, at which time the customer has control. The allocated transaction price for the return transportation and treatment revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities at which point the destruction or conversion and proof of receipt and treatment are performed on the container. Consideration received and allocated to the transportation and treatment performance obligation is recorded as a contract liability until the services are performed. Through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the return transportation and treatment element is recognized at the point of sale. Furthermore, the current and long-term

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

portions of amounts historically referred to deferred revenues (shown as Contract Liability on the condensed consolidated balance sheets) are determined through regression analysis and historical trends.

The VMI program includes terms that meet the “bill and hold” criteria and as such are recognized when the order is placed, title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse for the customer. During the three months ended September 30, 2018 and 2017, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $0.4 million and $1.0 million, respectively. As of September 30, 2018 and June 30, 2018, $1.7 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.

The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of September 30, 2018 was as follows (in thousands):



	September 30, 2018
	As Reported			Adjustments			Balance Without Adoption
Current contract asset	$	278		$	(278	)	$	—
Prepaid and other current assets	741			(13		)	728
Total current assets	17,112			(291		)	16,821
Long-term contract asset	60			(60		)	—
Total assets	33,896			(351		)	33,545
Current contract liability⁽¹⁾	1,801			2			1,803
Total current liabilities	6,254			2			6,256
Long-term contract liability⁽¹⁾	462			—			462
Total Liabilities	8,213			2			8,215
Accumulated Deficit	(1,649		)	(353		)	(2,002		)
Total stockholders' equity	25,683			(353		)	25,330
Total liabilities and stockholders' equity	33,896			(351		)	33,545

(1): Prior period contract liabilities were referred to as deferred revenue.

The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the three months ended September 30, 2018 was as follows (in thousands):



	September 30, 2018
	As Reported		Adjustments			Balance Without Adoption
Revenues	$	10,293	$	35		$	10,328
Cost of revenues	6,941		37			6,978
Gross profits	3,352		(2		)	3,350
Selling, general and administrative	3,026		13			3,039
Operating income	125		(15		)	110
Net income	70		(15		)	55

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

performance obligations. Incremental costs to obtain contracts that are deemed to be recoverable under the new accounting guidance, primarily related to the payment of sales incentives for contracts in the route-based pickup service category, are capitalized as contract costs and included in prepaids and other current assets in the amount of $13 thousand as of September 30, 2018. The amortization of capitalized sales incentives, which is included in selling, general and administrative expense, totaled $1 thousand for the three months ended September 30, 2018.

Income Taxes: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. A valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The Company's deferred tax liability of $0.3 million reflects the accumulated tax expense related to the effect of indefinite lived assets, such as goodwill, which cannot be used as a source of future taxable income in evaluating the need for a valuation against deferred tax assets offset by realizable deferred tax assets associated with alternative minimum tax credits of $0.2 million.

Accounts Receivable: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts.

Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the prior year ended June 30, 2018 and there have been no triggering events since that date that would warrant further impairment testing.

Stock-Based Compensation: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).

Fair Value of Financial Instruments: The Company considers the fair value of all financial instruments, including cash, accounts receivable and accounts payable to approximate their carrying values at September 30, 2018 and June 30, 2018 due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.

Reclassification of Prior Year Presentation in the Consolidated Statements of Cash Flows: Certain prior year amounts have been reclassified for consistency with the current year presentation in the Consolidated Statements of Cash Flows. The change in classification does not affect previously reported cash flows from operating activities, investing activities or financing activities in the Consolidated Statements of Cash Flows.

NOTE 4 – RECENTLY ISSUED ACCOUNTING STANDARDS

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

NOTE 5 – INCOME TAXES

The Company’s effective tax rate for the three months ended September 30, 2018 was 34.6% reflecting primarily deferred tax expense related to the effect of indefinite lived assets, such as goodwill, which cannot be used as a source of future taxable income in evaluating the need for a valuation allowance against deferred tax assets as well as estimated state income tax. For the three months ended September 30, 2018, the Company recorded total income tax expense of $37 thousand, consisting of estimated federal income tax expense of $33 thousand and estimated state income tax expense of $4 thousand. For the three months ended September 30, 2017, the Company recorded a total income tax expense of $7 thousand, consisting primarily of state income taxes.

NOTE 6 - NOTES PAYABLE AND LONG-TERM DEBT

On March 29, 2017, the Company entered into to a credit agreement with a commercial bank which was subsequently amended on June 29, 2018 to extend the maturity date by two years (“Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a $14.0 million credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the Company’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lesser of (i) 50% of eligible inventory and (ii) $3.0 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% depending on the Company’s cash flow leverage ratio. The interest rate as of September 30, 2018 was approximately 4.63%. The Company pays a fee of 0.25% per annum on the unused amount of the credit facility.

At September 30, 2018, long-term debt consisted of the following (in thousands):



Term loan, bearing interest at 4.25%, monthly payments of $43; maturing March 2022.	$	1,852
Less: current portion	517
Long-term debt, net of current portion	$	1,335

The Company has availability under the Credit Agreement of $12.1 million ($6.0 million for the working capital and $6.1 million for the acquisitions) as of September 30, 2018. The Company also has $40,000 in letters of credit outstanding as of September 30, 2018.

The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain a maximum cash flow leverage ratio of no more than 3.0 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The Credit Agreement, which expires on March 29, 2021 for the working capital portion of the Credit Agreement, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders. The leverage ratio covenant may limit the amount available under the Credit Agreement.

Payments due on long-term debt during each of the five years subsequent to September 30, 2018 are as follows (in thousands):



Twelve Months Ending September 30,
2019	$	517
2020	517
2021	517
2022	301
	$	1,852

The Company utilizes performance bonds to support operations based on certain state requirements. At September 30, 2018, the Company had performance bonds outstanding covering financial assurance up to $1.0 million.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 7 – STOCK-BASED COMPENSATION

Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant) net of applicable unvested shares forfeited. During the three months ended September 30, 2018 and 2017, stock-based compensation amounts are as follows (in thousands):



	Three-Months Ended September 30,
	2018			2017
Stock-based compensation expense included in:
Cost of revenues	$	(2	)	$	14
Selling, general and administrative	103			107
Total	$	101		$	121

NOTE 8 - EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method.

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):



	Three-Months Ended September 30,
	2018		2017
Net income, as reported	$	70	$	75

Weighted average common shares outstanding	16,082		16,008
Effect of dilutive stock options	7		85
Weighted average diluted common shares outstanding	16,089		16,093

Net income per common share
Basic and diluted	$	0.00	$	0.00

Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive	851		231

NOTE 9 - EQUITY TRANSACTIONS

During the three months ended September 30, 2018 and 2017, there were no exercises of stock options to purchase shares of the Company's common stock. As of September 30, 2018, there was $0.2 million of stock compensation expense related to non-vested awards which is expected to be recognized over a weighted average period of 2.4 years.

During the twelve months ended June 30, 2018, the Company issued 20,617 shares of common stock as a portion of consideration for a third-party lease agreement. The shares were issued at $4.00 per share based on the closing price on the date of grant. This issuance was exempt from registration pursuant to Section 4(a)(2) of the Securities Act. Non-cash expense recorded during the three months ended September 30, 2018 was $12 thousand. The remaining cost will be amortized over the life of the lease and is included in Prepaid and Other Current Assets or Other Assets on the balance sheet.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 10 – GOODWILL AND INTANGIBLE ASSETS

At September 30, 2018 and June 30, 2018, intangible assets consisted of the following (in thousands):



		September 30, 2018							June 30, 2018
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount
Customer relationships	7 years	$	3,007	$	(1,026	)	$	1,981	$	3,007	$	(919	)	$	2,088
Permits	6 - 15 years	1,610		(416		)	1,194		1,459		(390		)	1,069
Patents	5 - 17 years	395		(281		)	114		383		(278		)	105
Trade name	7 years	270		(87		)	183		270		(77		)	193
Non-compete	5 years	117		(53		)	64		117		(47		)	70
Total intangible assets, net		$	5,399	$	(1,863	)	$	3,536	$	5,236	$	(1,711	)	$	3,525

During both the three months ended September 30, 2018 and 2017, amortization expense was $0.2 million. There have been no changes in the carrying amount of goodwill since June 30, 2018.

As of September 30, 2018, future amortization of intangible assets is as follows (in thousands):



Twelve Months Ending September 30,
2019	$	643
2020	634
2021	627
2022	599
2023	441
Thereafter	592
	$	3,536

NOTE 11 – INVENTORY

The components of inventory are as follows (in thousands):



	September 30, 2018		June 30, 2018
Raw materials	$	1,419	$	1,323
Finished goods	2,725		2,663
Total	$	4,144	$	3,986

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q contains certain forward-looking statements and information relating to the Company and its subsidiaries that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to the Company’s management. When used in this report, the words "will," "may," "position," "plan," "potential," "continue," "anticipate," "believe," "expect," "estimate," "project" and "intend" and words or phrases of similar import, as they relate to the Company or its subsidiaries or Company management, are intended to identify forward-looking statements. Such statements reflect the known and unknown risks, uncertainties and assumptions related to certain factors, including without limitations, competitive factors, general economic conditions, customer relations, relationships with vendors, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, onetime events and other factors described herein. Based upon changing conditions, should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in this Quarterly Report on Form 10-Q or refer to our Annual Report on Form 10-K. Actual results may vary materially. You are cautioned not to place undue reliance on any forward-looking statements. You should also understand that it is not possible to predict or identify all such factors and as such should not consider the preceding list or the risk factors to be a complete list of all potential risks and uncertainties. The Company does not intend to update these forward-looking statements.

GENERAL

Sharps Compliance Corp. is a leading national healthcare waste management provider specializing in regulated waste streams including medical, pharmaceutical and hazardous. Our services facilitate the safe and proper collection, transportation and environmentally-responsible treatment of regulated waste from customers in multiple healthcare-related markets. The markets we manage are small to medium-size generators of healthcare waste including professional offices (ambulatory surgical centers, physician groups, dentists and veterinarians), assisted living and long-term care facilities, government agencies, home health care, retail clinics and immunizing pharmacies. Additionally, our mailback solutions are positioned to manage waste generated in the home setting such as sharps, lancets and ultimate-user medications which generates business relationships with pharmaceutical manufacturers and other markets to provide safe and proper disposal. Lastly, we maintain a strong distribution network for the sale of our solutions within the aforementioned markets.

We assist our customers in determining solutions that best fit their needs for the collection, transportation and treatment of regulated medical, pharmaceutical and hazardous waste. Our differentiated approach provides our customers the flexibility to transport waste via direct route-based services, the United States Postal Service (“USPS”) or common carrier dependent upon quantity of waste generated, cost savings and facility needs. Our comprehensive services approach includes a single point of contact, consolidated billing, integrated manifest and proof of destruction repository. Furthermore, we provide comprehensive tracking and reporting tools that enable our customers to meet complex medical, pharmaceutical and hazardous waste disposal and compliance requirements. We believe the fully-integrated nature of our operations is a key factor leading to our success and continued recurring revenue growth.

Our flagship products are the Sharps Recovery System™ and MedSafe® Medication Disposal System. These two product offerings account for over 50% of company revenues. The Sharps Recovery System is a comprehensive medical waste management mailback solution used in all markets due to its cost effective nature and nationwide availability. The MedSafe solution meets the immediate needs of an increasing community risk associated with unused, ultimate-user, medications. Developed in accordance with the Drug Enforcement Administration (“DEA”) implementation of the Secure and Responsible Drug Disposal Act of 2010 (the “Act”), MedSafe is a superior solution used in both private and public sectors to properly remove medications from communities and aid in the prevention of drug abuse.

Over the past few years, the Company has made a series of investments to build a robust direct service, route-based, pickup offering for medical, pharmaceutical and hazardous waste. We have built an infrastructure capable of covering more than 50% of the U.S. population with permitted trucks, transfer stations and treatment facilities. We continue to add routes and the infrastructure required for operational efficiency to reach more customers and prospects directly. Our route-based services, matched with comprehensive mailback solutions, offer us a key differentiator in the market and the ability to capitalize on larger or regional contracts within the healthcare market. With the growth in infrastructure to support the route-based service, we have strategically added new distribution for faster and more cost-effective delivery of products to customers.

We continue to develop new solutions to meet market demands. Over the past five years we have added a robust portfolio of ultimate-user medication disposal solutions for controlled substances, DEA-inventory controlled medication disposal for professionals, route-based services for medical, pharmaceutical and hazardous waste and the TakeAway Recycling System™ for single-use devices (SUDs). The TakeAway Recycle System is an exciting new solution for the Company as it is a relatively new solution for the market. Single-use devices are constructed of materials capable of being recycled including plastics, metals, circuit boards and batteries. With an increased emphasis for more sustainable solutions, the TakeAway Recycle System is a much needed complement to the single-use device market.

RESULTS OF OPERATIONS

The following analyzes changes in the consolidated operating results and financial condition of the Company during the three months ended September 30, 2018 and 2017. The following table sets forth for the periods indicated certain items from the Company's Condensed Consolidated Statements of Operations (dollars in thousands and percentages expressed as a percentage of revenues, unaudited):



	Three-Months Ended September 30,
	2018			%		2017			%
Revenues	$	10,293		100	%	$	9,683		100.0	%
Cost of revenues	6,941			67.4	%	6,655			68.7	%
Gross profit	3,352			32.6	%	3,028			31.3	%
SG&A expense	3,026			29.4	%	2,725			28.1	%
Depreciation and amortization	201			2.0	%	202			2.1	%
Operating income	125			1.2	%	101			1.0	%
Total other expense	(18		)	(0.2	)%	(19		)	(0.2	)%
Income before income taxes	107			1.0	%	82			0.8	%
Income tax expense	37			0.4	%	7			0.1	%
Net Income	$	70		0.7	%	$	75		0.8	%

THREE MONTHS ENDED SEPTEMBER 30, 2018 AS COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2017

Total revenues for the three months ended September 30, 2018 of $10.3 million increased by $0.6 million, or 6.3%, over the total revenues for the three months ended September 30, 2017 of $9.7 million. The increase in revenue is mainly due to increased billings across the Retail and Professional markets partially offset by decreased billings in the Pharmaceutical Manufacturer and Environmental markets. The components of billings by market are as follows (in thousands, unaudited):



	Three-Months Ended September 30,
	2018			2017			Variance
BILLINGS BY MARKET:
Professional	$	3,674		$	3,101		$	573
Retail	2,260			1,400			860
Home Health Care	1,927			2,001			(74		)
Pharmaceutical Manufacturer	808			1,532			(724		)
Assisted Living	645			604			41
Government	597			554			43
Environmental	103			434			(331		)
Other	290			218			72
Subtotal	10,304			9,844			460
GAAP Adjustment *	(11		)	(161		)	150
Revenue Reported	$	10,293		$	9,683		$	610

*Represents the net impact of the revenue recognition adjustments required to arrive at reported generally accepted accounting principles (“GAAP”) revenue. Customer billings include all invoiced amounts associated with products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales, (ii) recognition of certain revenue associated with products returned for treatment and destruction and (iii) provisions for certain rebates, product returns and discounts to customers which are accounted for as reductions in sales in the same period to related sales are recorded. The difference between customer billings and GAAP revenue is reflected in the Company’s balance sheet as contract liability. See Note 3 “Revenue Recognition” in “Notes to Condensed Consolidated Financial Statements”.

The components of billings by solution are as follows (in thousands, unaudited):



	Three-Months Ended September 30,
	2018			% Total		2017⁽³⁾			% Total
BILLINGS BY SOLUTION:
Mailbacks	$	5,618		54.5	%	$	5,626		57.2	%
Route-based pickup services	2,128			20.7	%	1,761			17.9	%
Unused medications	1,639			15.9	%	1,172			11.9	%
Third party treatment services	102			1.0	%	434			4.4	%
Other ⁽¹⁾	817			7.9	%	851			8.6	%
Total billings	$	10,304		100.0	%	$	9,844		100.0	%
GAAP adjustment ⁽²⁾	(11		)			(161		)
Revenue reported	$	10,293				$	9,683


(1)	The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items.

(2)

Represents the net impact of the revenue recognition adjustment required to arrive at reported generally accepted accounting principles (“GAAP”) revenue. Customer billings include all invoiced amounts associated with products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales, (ii) recognition of certain revenue associated with products returned for treatment and destruction and (iii) provisions for certain rebates, product returns and discounts to customers which are accounted for as reductions in sales in the same period to related sales are recorded. The difference between customer billings and GAAP revenue is reflected in the Company’s balance sheet as contract liability.


(3)	Certain prior year amounts have been reclassified to conform to current year presentation.

The increase in billings was mainly attributable to increased billings in the Retail ($0.9 million) and Professional ($0.6 million) markets, partially offset by decreased billings in the Pharmaceutical Manufacturer ($0.7 million) and Environmental ($0.3 million) markets. The increase in Retail billings was primarily related to flu shot orders and increased order activity for unused medication solutions, including the MedSafe in the Retail pharmacy market. The increase in Professional market billings reflected organic growth as the Company continued its focus on securing customers from the small to medium quantity generator sector made up of physicians, clinics, dentists, surgery centers, veterinarians and other healthcare professionals, who typically use a combination of the cost-effective and convenient Sharps Recovery System and the Company’s route-based pick-up services. The decrease in Pharmaceutical Manufacturer billings was due to timing of inventory builds for patient support programs. Billings for Mailbacks were consistent with the prior period at $5.6 million and represented 54.5% of total billings. Billings for Route-Based Pickup Services increased 20.8% to $2.1 million as compared to $1.8 million in the prior year period and represented 20.7% of total billings. Billings for Unused Medications increased 39.8% to $1.6 million as compared to $1.2 million in the prior year period and represented 15.9% of total billings.

Cost of revenues for the three months ended September 30, 2018 of $6.9 million was 67.4% of revenues. Cost of revenues for the three months ended September 30, 2017 of $6.7 million was 68.7% of revenues. The gross margin for the three months ended September 30, 2018 of 32.6% increased compared to the gross margin for the three months ended September 30, 2017 of 31.3% due to higher revenue.

Selling, general and administrative (“SG&A”) expenses for the three months ended September 30, 2018 and 2017 were $3.0 million and $2.7 million, respectively. The increase in SG&A expense was due to continued investment in sales and marketing.

The Company reported an operating income of $0.1 million for both the three months ended September 30, 2018 and 2017.

The Company reported an income before income taxes of $0.1 million for both the three months ended September 30, 2018 and 2017.

The Company’s effective tax rate for the three months ended September 30, 2018 was 34.6% reflecting primarily deferred tax expense related to indefinite lived assets, such as goodwill, which cannot be used as a source of future taxable income in evaluating the need for a valuation allowance against deferred tax assets. The Company's effective tax rate for the three months ended September 30, 2017 was 8.5% reflecting primarily state income taxes.

The Company reported a net income of $0.1 million for both the three months ended September 30, 2018 and 2017.

The Company reported basic and diluted income per share of $0.00 for the three months ended September 30, 2018 and 2017.

PROSPECTS FOR THE FUTURE

The Company continues to focus on core markets and solution offerings that fuel growth. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living/long-term care, retail pharmacies and clinics, and the professional market which is comprised of physicians, dentists, surgery centers and veterinary practices. These markets require cost-effective services for managing medical, pharmaceutical and hazardous waste.

The Company believes its growth opportunities are supported by the following:

•

A large professional market that consists of dentists, veterinarians, clinics, private practice physicians, urgent care facilities, ambulatory surgical centers and other healthcare facilities. This regulated market consists of small to medium quantity generators of medical, pharmaceutical and hazardous waste where we can offer a lower cost to service with solutions to match individual facility needs. The Company addresses this market from two directions: (i) field sales which focus on larger-dollar and nationwide opportunities where we can integrate the route-based pickup service along with our mailback solutions to create a comprehensive medical waste management offering and (ii) inside and online sales which focus on the individual or small group professional offices, government agencies, smaller retail pharmacies and clinics and assisted living/long-term care facilities. The Company is able to compete more aggressively in the medium quantity generator market with the addition of route-based services where the mailback may not be as cost effective. The Company’s route-based business provides direct service to areas encompassing over 50% of the U.S. population.

•

In July 2015 and December 2015, the Company augmented its network of medical and hazardous waste service providers with acquisitions of route-based pickup services in the Northeast serving Pennsylvania, Maryland, Ohio and other neighboring states. In July 2016, the Company acquired another route-based pickup service which expanded service to New York and New Jersey and strengthened the Company’s position in the Northeast. Through a combination of acquisition and organic growth, the Company now offers route-based pickup services in a twenty-four (24) state region of the South, Southeast and Northeast portions of the United States. The Company directly serves more than 11,100 customer locations with route-based pickup services. With the addition of these route-based pickup regions and the network of medical and hazardous waste service providers servicing the entire U.S., the Company offers customers a blended product portfolio to effectively manage multi-site and multi-sized locations, including those that generate larger quantities of waste. The network has had a significant positive impact on our pipeline of sales opportunities - over 60% of this pipeline is attributable to opportunities providing comprehensive waste management service offerings where both the mailback and pickup service are integrated into the offering.

•

The changing demographics of the U.S. population – according to the U.S. Census Bureau, 2012 Population Estimates and National Projections, one out of five Americans will be 65 years or older by 2030, which will increase the need for cost-effective medical waste management solutions, especially in the long-term care and home healthcare markets. With multiple solutions for managing regulated healthcare-related waste, the Company delivers value as a single-source provider with blended mailback and route-based pickup services matched to the waste volumes of each facility.

•

The shift of healthcare from traditional settings to the retail pharmacy and clinic markets, where the Company focuses on driving increased promotion of the Sharps Recovery System. According to the Centers for Disease Control ("CDC"), 38.5% of adults received a flu shot and 28.2% of flu shots for adults were administered in a retail clinic. Over the flu seasons from 2011 to 2018, the Company saw growth in five years off 10% to 36% and declines in three years of 13% to 17%. Despite the volatility, Sharps believes the Retail market should continue to contribute to long-term growth for the Company as consumers increasingly use alternative sites, such as retail pharmacies, to obtain flu and other immunizations.

•

The passage of regulations for ultimate user medication disposal allows the Company to offer new solutions (MedSafe and TakeAway Medication Recovery System envelopes) that meet the regulations for ultimate user controlled substances disposal (Schedules II-V) to retail pharmacies. Additionally, with the new regulations, the Company is able to provide the MedSafe and TakeAway Medication Recovery Systems to assisted living and hospice to address a long standing issue within long-term care.

•

Local, state and federal agencies have growing needs for solutions to manage medical and pharmaceutical waste — the Company's Sharps Recovery System is ideal for as-needed disposal of sharps and other small quantities of medical waste generated within government buildings, schools and communities. The Company also provides TakeAway Medication Recovery System envelopes and MedSafe solutions to government agencies in need of proper and regulatory compliant medication disposal. The federal government, state agencies and non-profits are recognizing the need to fund programs that address prevention as it pertains to the opioid crisis. MedSafe and mailback envelopes for proper medication disposal are being funded for prevention programs.

•

With an increased number of self-injectable medication treatments and local regulations, the Company believes its flagship product, the Sharps Recovery System, continues to offer the best option for proper sharps disposal at an affordable price. The Company delivers comprehensive services to pharmaceutical manufacturers that sell high-dollar, self-injectable medications, which include data management, compliance reporting, fulfillment, proper containment with disposal, branding and conformity with applicable regulations. In addition, the Company provides self-injectors with online and retail purchase options of sharps mailback systems, such as the Sharp Recovery System and Complete Needle Collection & Disposal System, respectively.


•	A heightened interest by many commercial companies who are looking to improve workplace safety with proper sharps disposal and unused medication disposal solutions — the Company offers a variety of services to meet these needs, including the Sharps Secure Needle Disposal System, Sharps Recovery System, Spill Kits and TakeAway Medication Recovery System envelopes.

•

The Company continually develops new solution offerings such as ultimate user medication disposal (MedSafe and TakeAway Medication Recovery System), mailback services for DEA registrant expired inventory of controlled substances (TakeAway Medication Recovery System DEA Reverse Distribution for Registrants) and shipback services for collection and recycling of single-use medical devices from surgical centers and other healthcare facilities (TakeAway Recycle System).


•	The Company’s strong financial position with a cash balance of $5.1 million, debt of $1.9 million and additional availability under the Credit Agreement.

LIQUIDITY AND CAPITAL RESOURCES

Cash Flow

Cash flow has historically been primarily influenced by demand for products and services, operating margins and related working capital needs as well as more strategic activities including acquisitions, stock repurchases and fixed asset additions. Cash decreased by $6 thousand to $5.15 million at September 30, 2018 from $5.16 million at June 30, 2018 due to the following:


•	Cash Flows from Operating Activities - Working capital increased by $0.6 million to $10.9 million at September 30, 2018 from $10.3 million at June 30, 2018. The increase in working capital is attributed to:


•	an increase in accounts receivable of $0.4 million to $6.8 million at September 30, 2018 from $6.4 million at June 30, 2018 due to timing of billings and collections.


•	an increase in current contract assets net of the decrease in current contract liabilities of $0.4 million to $0.3 million contract assets and $1.8 million contract liability at September 30, 2018 from a $1.9 million contract liability at June 30, 2018 due primarily to the cumulative effect of implementing the new revenue recognition guidance.


•	an increase in accounts payable and accrued liabilities of $0.4 million due to the timing of purchases and payments to vendors.


•	Cash Flows used in Investing Activities - Investing activities include permitting and capital expenditures of $0.2 million for normal permitting, plant and equipment additions.


•	Cash Flows used in Financing Activities - Financing activities include repayments of debt of $0.2 million.

Off-Balance Sheet Arrangements

The Company was not a party to any off-balance sheet transactions as defined in Item 303 of Regulation S-K for the three months ended September 30, 2018 and the year ended June 30, 2018.

Credit Facility

The Company has availability under the Credit Agreement of approximately $12.1 million ($6.0 million for the working capital and $6.1 million for the acquisitions) as of September 30, 2018. The Company also had $40,000 in letters of credit outstanding as of September 30, 2018.

Management believes that the Company’s current cash resources (cash on hand and cash flows from operations) will be sufficient to fund operations for at least the next twelve months.

CRITICAL ACCOUNTING POLICIES

Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties and could potentially result in materially different results under different assumptions and conditions. The Company's critical accounting policies are included in the discussion entitled Critical Accounting Policies in Item 7. Management's Discussions and Analysis of Financial Condition and Results of Operations in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as filed with the SEC. There were no material changes to the critical accounting policies disclosed in the Annual Report on Form 10-K other than the implementation of the new revenue recognition standard described in Note 3 to the condensed consolidated financial statements.

RECENTLY ISSUED ACCOUNTING STANDARDS

In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company maintains “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”) as appropriate, to allow timely decisions regarding required disclosure. The Company conducted an evaluation (the “Evaluation”), under the supervision and with the participation of the CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures (“Disclosure Controls”) as of September 30, 2018, pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based upon this Evaluation, the CEO and CFO concluded that our Disclosure Controls were effective as of September 30, 2018.

Changes in Internal Control

During the three months ended September 30, 2018, there were no changes in the Company’s internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act), that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, the Company is involved in legal proceedings and litigation in the ordinary course of business. In the opinion of management, the outcome of such matters is not anticipated to have a material adverse effect on the Company’s consolidated financial position or consolidated results of operations.

ITEM 1A. RISK FACTORS

Refer to Item 1A. Risk Factors in the Company’s annual report on Form 10-K for the year ended June 30, 2018 for the Company’s risk factors. During the period ended September 30, 2018, there have been no changes to the Company’s risk factors.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None

ITEM 6. EXHIBITS



(a)	Exhibits:

31.1	Certification of Chief Executive Officer in accordance with Section 302 of the Sarbanes-Oxley Act (filed herewith)

31.2	Certification of Chief Financial Officer in accordance with Section 302 of the Sarbanes-Oxley Act (filed herewith)

32.1	Certification of Chief Executive Officer in accordance with Section 906 of the Sarbanes-Oxley Act (filed herewith)

32.2	Certification of Chief Financial Officer in accordance with Section 906 of the Sarbanes-Oxley Act (filed herewith)

101.INS	XBRL Instance Document (filed herewith)

101.SCH	XBRL Taxonomy Extension Schema Document (filed herewith)

101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith)

101.DEF	XBRL Taxonomy Extension Linkbase Document (filed herewith)

101.LAB	XBRL Taxonomy Extension Label Linkbase Document (filed herewith)

101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith)

ITEMS 3, 4 AND 5 ARE NOT APPLICABLE AND HAVE BEEN OMITTED.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	REGISTRANT:
	SHARPS COMPLIANCE CORP.

Dated: November 1, 2018	By: /s/ DAVID P. TUSA
	David P. Tusa
	Chief Executive Officer and President
	(Principal Executive Officer)



Dated: November 1, 2018	By: /s/ DIANA P. DIAZ
	Diana P. Diaz
	Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-31.1 2 exhibit3111.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

IN ACCORDANCE WITH SECTION 302 OF THE SARBANES-OXLEY ACT

I, David P. Tusa, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Sharps Compliance Corp.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.



Date: November 1, 2018	/s/David P. Tusa
	Chief Executive Officer and President
	(Principal Executive Officer)

EX-31.2 3 exhibit3121.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

IN ACCORDANCE WITH SECTION 302 OF THE SARBANES-OXLEY ACT

I, Diana P. Diaz, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Sharps Compliance Corp.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.



Date: November 1, 2018	/s/Diana P. Diaz
	Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1 4 exhibit3211.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

IN ACCORDANCE WITH SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the quarterly report of Sharps Compliance Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof, I, David P. Tusa, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:


(1)	The Form 10-Q report for the period ended September 30, 2018, filed with the Securities and Exchange Commission on November 1, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Form 10-Q report for the period ended September 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of Sharps Compliance Corp.



Date: November 1, 2018	/s/David P. Tusa
	Chief Executive Officer and President

EX-32.2 5 exhibit3221.htm EXHIBIT 32.2 Exhibit

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

IN ACCORDANCE WITH SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the quarterly report of Sharps Compliance Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof, I, Diana P. Diaz, Vice President and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:


(1)	The Form 10-Q report for the period ended September 30, 2018, filed with the Securities and Exchange Commission on November 1, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Form 10-Q report for the period ended September 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of Sharps Compliance Corp.



Date: November 1, 2018	/s/Diana P. Diaz
	Vice President and Chief Financial Officer

EX-101.INS 6 smed-20180930.xml XBRL INSTANCE DOCUMENT 0000898770 2018-07-01 2018-09-30 0000898770 2018-10-30 0000898770 2018-06-30 0000898770 2018-09-30 0000898770 2017-07-01 2017-09-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000898770 us-gaap:CommonStockMember 2018-09-30 0000898770 us-gaap:CommonStockMember 2018-06-30 0000898770 us-gaap:CommonStockMember 2017-06-30 0000898770 us-gaap:TreasuryStockMember 2018-06-30 0000898770 2017-06-30 0000898770 2017-07-01 2018-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2018-06-30 0000898770 us-gaap:CommonStockMember 2017-07-01 2018-06-30 0000898770 us-gaap:RetainedEarningsMember 2018-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000898770 us-gaap:TreasuryStockMember 2017-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000898770 us-gaap:RetainedEarningsMember 2017-07-01 2018-06-30 0000898770 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000898770 us-gaap:TreasuryStockMember 2018-09-30 0000898770 us-gaap:RetainedEarningsMember 2018-09-30 0000898770 us-gaap:RetainedEarningsMember 2017-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000898770 2017-09-30 0000898770 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-30 0000898770 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-09-30 0000898770 smed:UnusedMedicationsMember 2018-07-01 2018-09-30 0000898770 smed:ThirdPartyTreatmentServicesMember 2018-07-01 2018-09-30 0000898770 us-gaap:ProductAndServiceOtherMember 2017-07-01 2017-09-30 0000898770 smed:UnusedMedicationsMember 2017-07-01 2017-09-30 0000898770 smed:RouteBasedPickupServicesMember 2017-07-01 2017-09-30 0000898770 smed:ThirdPartyTreatmentServicesMember 2017-07-01 2017-09-30 0000898770 us-gaap:ProductAndServiceOtherMember 2018-07-01 2018-09-30 0000898770 smed:MailbacksMember 2017-07-01 2017-09-30 0000898770 smed:RouteBasedPickupServicesMember 2018-07-01 2018-09-30 0000898770 smed:MailbacksMember 2018-07-01 2018-09-30 0000898770 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2018-09-30 0000898770 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2018-09-30 0000898770

2018-10-01

2018-09-30 0000898770

2019-10-01

2018-09-30 0000898770 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 0000898770 smed:CreditAgreementMember smed:TermLoanMember 2018-09-30 0000898770 smed:WorkingCapitalMember smed:CreditAgreementMember 2018-09-30 0000898770 smed:CreditAgreementMember 2018-06-29 2018-06-29 0000898770 us-gaap:SuretyBondMember 2018-09-30 0000898770 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember smed:CreditAgreementMember 2018-06-29 0000898770 smed:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-06-29 2018-06-29 0000898770 srt:MaximumMember smed:CreditAgreementMember 2018-06-29 2018-06-29 0000898770 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember smed:CreditAgreementMember 2018-06-29 2018-06-29 0000898770 smed:CreditAgreementMember smed:TermLoanMember 2018-06-29 2018-06-29 0000898770 smed:CreditAgreementMember 2018-06-29 0000898770 us-gaap:LetterOfCreditMember smed:CreditAgreementMember 2018-06-29 0000898770 smed:CreditAgreementMember 2018-09-30 0000898770 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember smed:CreditAgreementMember 2018-09-30 0000898770 smed:WorkingCapitalMember smed:CreditAgreementMember 2018-06-29 0000898770 us-gaap:LetterOfCreditMember smed:CreditAgreementMember 2018-09-30 0000898770 srt:MaximumMember smed:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-06-29 2018-06-29 0000898770 srt:MinimumMember smed:CreditAgreementMember 2018-06-29 2018-06-29 0000898770 smed:CreditAgreementMember smed:TermLoanMember 2018-07-01 2018-09-30 0000898770 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000898770 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000898770 us-gaap:CostOfSalesMember 2017-07-01 2017-09-30 0000898770 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0000898770 us-gaap:ConstructionPermitsMember 2018-09-30 0000898770 us-gaap:PatentsMember 2018-09-30 0000898770 us-gaap:NoncompeteAgreementsMember 2018-07-01 2018-09-30 0000898770 us-gaap:ConstructionPermitsMember 2018-06-30 0000898770 us-gaap:CustomerRelationshipsMember 2018-07-01 2018-09-30 0000898770 us-gaap:NoncompeteAgreementsMember 2018-06-30 0000898770 us-gaap:TradeNamesMember 2018-09-30 0000898770 us-gaap:PatentsMember 2018-06-30 0000898770 us-gaap:CustomerRelationshipsMember 2018-09-30 0000898770 us-gaap:CustomerRelationshipsMember 2018-06-30 0000898770 us-gaap:TradeNamesMember 2018-06-30 0000898770 us-gaap:NoncompeteAgreementsMember 2018-09-30 0000898770 us-gaap:TradeNamesMember 2018-07-01 2018-09-30 0000898770 srt:MinimumMember us-gaap:PatentsMember 2018-07-01 2018-09-30 0000898770 srt:MaximumMember us-gaap:PatentsMember 2018-07-01 2018-09-30 0000898770 srt:MinimumMember us-gaap:ConstructionPermitsMember 2018-07-01 2018-09-30 0000898770 srt:MaximumMember us-gaap:ConstructionPermitsMember 2018-07-01 2018-09-30 xbrli:shares iso4217:USD xbrli:shares xbrli:pure smed:state_region iso4217:USD false --06-30 Q1 2019 2018-09-30 10-Q 0000898770 16082021 false Non-accelerated Filer SHARPS COMPLIANCE CORP true 2100000 1700000 3000000 3.0 P2Y P1M 1.15 21000 17000 24 0.8 0.5 0.75 1000000 400000 69000 119000

1500000

1894000

6370000

6800000

2061000

2042000

28621000

28722000

476000

101000

14000

107000

121000

-2000

103000

101000

102000

110000

200000

231000

851000

33231000

33896000

-351000

33545000

16250000

17112000

-291000

16821000

1000

13000

4675000

5160000

5155000

5149000

5155000

5149000

485000

-6000

0.01

20000000

16377636

16082021

164000

0.564

0.182

0.045

0.121

0.088

0.545

0.207

0.010

0.159

0.079

300000

278000

-278000

60000

-60000

1894000

1801000

2000

1803000

470000

462000

900000

6655000

37000

6978000

6941000

338000

5000

4000

0.030

0.025

0.0425

43000

P5Y

2000

33000

25000

2000

33000

200000

300000

202000

201000

390000

391000

0.00

0.346

200000

P2Y4M24D

33000

P15Y

P17Y

P6Y

P5Y

P7Y

P5Y

P7Y

1711000

390000

919000

47000

278000

77000

1863000

416000

1026000

53000

281000

87000

592000

643000

441000

599000

627000

634000

5236000

1459000

3007000

117000

383000

270000

5399000

1610000

3007000

117000

395000

270000

3525000

1069000

2088000

70000

105000

193000

3536000

1194000

1981000

64000

114000

183000

2000

6735000

3028000

-2000

3350000

3352000

1000000.0

82000

107000

7000

37000

3000

8000

-29000

365000

-269000

447000

25000

-101000

72000

39000

-124000

16000

85000

7000

24000

23000

17000

24000

2663000

2725000

3986000

4144000

1323000

1419000

5000

12000

8057000

8213000

2000

8215000

33231000

33896000

-351000

33545000

5992000

6254000

2000

6256000

40000

0.0463

6000000.0

2000000.0

8000000.0

14000000.0

6000000

6100000

12100000

0.0025

1852000

537000

517000

301000

517000

1465000

1335000

-150000

-273000

-242000

908000

386000

75000

-672000

-15000

55000

70000

-19000

-18000

101000

-15000

110000

125000

149000

143000

130000

137000

41000

163000

235000

79000

739000

741000

-13000

728000

3000

6572000

6310000

5000

17000

150000

-2057000

-1649000

-353000

-2002000

300000

9683000

5465000

1761000

434000

1172000

851000

35000

10328000

10293000

5607000

2128000

102000

1639000

817000

P9M

P1Y

2725000

13000

3039000

3026000

121000

101000

16304027

295615

16377636

295615

16377636

295615

4000

20617

52992

83000

-1000

1000

25287000

28063000

163000

-1385000

-1554000

25174000

28621000

164000

-2057000

-1554000

25683000

-353000

25330000

28722000

164000

-1649000

-1554000

300000

295615

1554000

16093000

16089000

16008000

16082000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments due on long-term debt during each of the five years subsequent to </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Twelve Months Ending September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">301</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a number of practical expedient elections related to the new accounting guidance, including: (i) right to invoice practical expedient that allows revenue for route-based pickup services to be recognized in the amount to which the Company has a right to invoice over time; (ii) sales and use taxes have been excluded from the transaction price; (iii) for incremental costs to obtain a contract that would be recognized over one year or less, the Company expenses those costs as incurred; and (iv) at the implementation date, new guidance was applied only to contracts that were not completed as of the date of initial application.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fair Value of Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">: The Company considers the fair value of all financial instruments, including cash, accounts receivable and accounts payable to approximate their carrying values at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL AND INTANGIBLE ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="27" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,981</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(919</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,088</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Permits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 - 15 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,610</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,194</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(390</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,069</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">5 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(77</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,399</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,863</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,536</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,236</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,711</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,525</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During both the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, amortization expense was </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">. There have been </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> changes in the carrying amount of goodwill since </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, future amortization of intangible assets is as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Twelve Months Ending September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">643</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">634</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,536</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Goodwill and Other Identifiable Intangible Assets:</font><font style="font-family:inherit;font-size:10pt;"> Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment during the prior year ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and there have been no triggering events since that date that would warrant further impairment testing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. A valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The Company's deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> reflects the accumulated tax expense related to the effect of indefinite lived assets, such as goodwill, which cannot be used as a source of future taxable income in evaluating the need for a valuation against deferred tax assets offset by realizable deferred tax assets associated with alternative minimum tax credits of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Without Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current contract asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">741</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term contract asset</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,896</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current contract liability</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,801</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,803</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term contract liability</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,213</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated Deficit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,649</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(353</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,002</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(353</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1): Prior period contract liabilities were referred to as deferred revenue.</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Without Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,293</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,941</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,350</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,039</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Reclassification of Prior Year Presentation in the Consolidated Statements of Cash Flows:</font><font style="font-family:inherit;font-size:10pt;"> Certain prior year amounts have been reclassified for consistency with the current year presentation in the Consolidated Statements of Cash Flows. The change in classification does not affect previously reported cash flows from operating activities, investing activities or financing activities in the Consolidated Statements of Cash Flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Accounts Receivable</font><font style="font-family:inherit;font-size:10pt;">: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue, net of applicable sales tax, when performance obligations are satisfied through the transfer of control of promised goods or services to the Company’s customers. Control transfers once a customer has the ability to direct the use of, and obtain substantially all of the benefits from, the promised goods or services. Outbound shipping and handling activities to customers are considered fulfillment activities with the exception of mailbacks sold as part of the vendor managed inventory ("VMI") program. Shipping and handling are considered separate performance obligations for mailbacks sold under the VMI program. For performance obligations satisfied at a point in time, which applies to all contract categories except for route-based pickup services, revenue recognition occurs when there is a transfer of control or completion of service. For performance obligations satisfied over time, which applies to the route-based pickup services contract category, revenue is recognized in the amount to which the Company has a right to invoice pursuant to the right to invoice practical expedient. Provisions for certain rebates, product returns and discounts to customers are estimated at the inception of the contract, updated as needed throughout the contract term, and accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other than the Company’s mailbacks and unused medication contract categories, the Company’s solutions have a single performance obligation. The Company's mailbacks and unused medication solutions have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the MedSafe and TakeAway Medication Recovery Systems referred to </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">as “mailbacks” or "unused medications") and can consist of up to two performance obligations, or units of measure, as follows: (1) the sale of the compliance and container system, and (2) return transportation and treatment service. For mailbacks that are p</font><font style="font-family:inherit;font-size:10pt;">art of the VMI program, there is an additional element, or unit of measure, for outbound transportation. For contracts with multiple performance obligations, an estimated stand-alone selling price is determined for all performance obligations. The consideration is then allocated to the performance obligations based on their relative stand-alone selling price. The selling price for performance obligations for transportation and treatment utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including the expected cost plus a margin.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The allocated transaction price for the sale of the compliance and container system is recognized upon delivery to the customer, at which time the customer has control. The allocated transaction price for the return transportation and treatment revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities at which point the destruction or conversion and proof of receipt and treatment are performed on the container. Consideration received and allocated to the transportation and treatment performance obligation is recorded as a contract liability until the services are performed. Through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the return transportation and treatment element is recognized at the point of sale. Furthermore, the current and long-term portions of amounts historically referred to deferred revenues (shown as Contract Liability on the condensed consolidated balance sheets) are determined through regression analysis and historical trends. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The VMI program includes terms that meet the “bill and hold” criteria and as such are recognized when the order is placed, title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse for the customer. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Revenue Recognition:</font><font style="font-family:inherit;font-size:10pt;"> In May 2014 and as subsequently amended, guidance for revenue recognition was issued which supersedes the revenue recognition requirements previously followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a full retrospective approach or a modified retrospective approach to implement the standard. The Company adopted the standard on July 1, 2018 using the modified retrospective approach, which involves retrospectively adopting the standard by recording a cumulative effect adjustment for all uncompleted contracts at July 1, 2018. This cumulative effect was </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> which decreased accumulated deficit (and increased stockholders' equity) and increased contract assets by </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. The impact that the new accounting guidance had on its consolidated financial statements and related disclosures included the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transportation and treatment performance obligations related to the mail back and unused medication solutions, which were historically accounted for as separate performance obligations, will be accounted for as a single performance obligation under the new revenue recognition guidance. The impact of this was not material. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain costs associated with obtaining long-term contracts with customers will be capitalized and amortized over the expected economic life of the contract in future periods. The impact of this was not material. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The new guidance changed the timing of revenue recognition on certain of the Company’s vendor managed inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a number of practical expedient elections related to the new accounting guidance, including: (i) right to invoice practical expedient that allows revenue for route-based pickup services to be recognized in the amount to which the Company has a right to invoice over time; (ii) sales and use taxes have been excluded from the transaction price; (iii) for incremental costs to obtain a contract that would be recognized over one year or less, the Company expenses those costs as incurred; and (iv) at the implementation date, new guidance was applied only to contracts that were not completed as of the date of initial application.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized revenue of </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> that was included in the current contract liability at July 1, 2018. The estimated timing of recognition of amounts included at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are as follows: for the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">September 30,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> - contract asset of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and contract liability of </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and for the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">September 30,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;"> - contract asset of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and contract liability of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">. The contract asset is related to VMI service agreements within the mailbacks contract type category when the revenue recognition exceeds the amount of consideration the Company was entitled to at the point in time of satisfying the performance obligation associated with the sale of the compliance and container system. The contract liability is related to the mailbacks and unused medications contract type categories in which cash consideration exceeds the transaction price allocated to completed performance obligations. Incremental costs to obtain contracts that are deemed to be recoverable under the new accounting guidance, primarily related to the payment of sales incentives for contracts in the route-based pickup service category, are capitalized as contract costs and included in prepaids and other current assets in the amount of </font><font style="font-family:inherit;font-size:10pt;">$13 thousand</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. The amortization of capitalized sales incentives, which is included in selling, general and administrative expense, totaled </font><font style="font-family:inherit;font-size:10pt;">$1 thousand</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, long-term debt consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loan, bearing interest at 4.25%, monthly payments of $43; maturing March 2022.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,335</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended<br clear="none"/>September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income, as reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average diluted common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,089</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,093</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per common share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, stock-based compensation amounts are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended<br clear="none"/>September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense included in:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="27" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,981</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(919</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,088</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Permits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 - 15 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,610</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,194</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(390</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,069</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">5 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(77</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,399</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,863</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,536</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,236</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,711</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,525</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of inventory are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,725</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,663</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,144</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,986</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, future amortization of intangible assets is as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Twelve Months Ending September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">643</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">634</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,536</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stock-Based Compensation</font><font style="font-family:inherit;font-size:10pt;">: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Revenue Recognition:</font><font style="font-family:inherit;font-size:10pt;"> In May 2014 and as subsequently amended, guidance for revenue recognition was issued which supersedes the revenue recognition requirements previously followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a full retrospective approach or a modified retrospective approach to implement the standard. The Company adopted the standard on July 1, 2018 using the modified retrospective approach, which involves retrospectively adopting the standard by recording a cumulative effect adjustment for all uncompleted contracts at July 1, 2018. This cumulative effect was </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> which decreased accumulated deficit (and increased stockholders' equity) and increased contract assets by </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. The impact that the new accounting guidance had on its consolidated financial statements and related disclosures included the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transportation and treatment performance obligations related to the mail back and unused medication solutions, which were historically accounted for as separate performance obligations, will be accounted for as a single performance obligation under the new revenue recognition guidance. The impact of this was not material. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain costs associated with obtaining long-term contracts with customers will be capitalized and amortized over the expected economic life of the contract in future periods. The impact of this was not material. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The new guidance changed the timing of revenue recognition on certain of the Company’s vendor managed inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made a number of practical expedient elections related to the new accounting guidance, including: (i) right to invoice practical expedient that allows revenue for route-based pickup services to be recognized in the amount to which the Company has a right to invoice over time; (ii) sales and use taxes have been excluded from the transaction price; (iii) for incremental costs to obtain a contract that would be recognized over one year or less, the Company expenses those costs as incurred; and (iv) at the implementation date, new guidance was applied only to contracts that were not completed as of the date of initial application.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="13" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">% Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">% Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">REVENUES BY SOLUTION:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mailbacks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">54.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">56.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Route-based pickup services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,128</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">20.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,761</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">18.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unused medications</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,639</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">15.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third party treatment services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">817</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8.8</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,293</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,683</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:25px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:25px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:1px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Certain prior year amounts have been reclassified to conform to current year presentation.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue, net of applicable sales tax, when performance obligations are satisfied through the transfer of control of promised goods or services to the Company’s customers. Control transfers once a customer has the ability to direct the use of, and obtain substantially all of the benefits from, the promised goods or services. Outbound shipping and handling activities to customers are considered fulfillment activities with the exception of mailbacks sold as part of the vendor managed inventory ("VMI") program. Shipping and handling are considered separate performance obligations for mailbacks sold under the VMI program. For performance obligations satisfied at a point in time, which applies to all contract categories except for route-based pickup services, revenue recognition occurs when there is a transfer of control or completion of service. For performance obligations satisfied over time, which applies to the route-based pickup services contract category, revenue is recognized in the amount to which the Company has a right to invoice pursuant to the right to invoice practical expedient. Provisions for certain rebates, product returns and discounts to customers are estimated at the inception of the contract, updated as needed throughout the contract term, and accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other than the Company’s mailbacks and unused medication contract categories, the Company’s solutions have a single performance obligation. The Company's mailbacks and unused medication solutions have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the MedSafe and TakeAway Medication Recovery Systems referred to </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">as “mailbacks” or "unused medications") and can consist of up to two performance obligations, or units of measure, as follows: (1) the sale of the compliance and container system, and (2) return transportation and treatment service. For mailbacks that are p</font><font style="font-family:inherit;font-size:10pt;">art of the VMI program, there is an additional element, or unit of measure, for outbound transportation. For contracts with multiple performance obligations, an estimated stand-alone selling price is determined for all performance obligations. The consideration is then allocated to the performance obligations based on their relative stand-alone selling price. The selling price for performance obligations for transportation and treatment utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including the expected cost plus a margin.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The allocated transaction price for the sale of the compliance and container system is recognized upon delivery to the customer, at which time the customer has control. The allocated transaction price for the return transportation and treatment revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities at which point the destruction or conversion and proof of receipt and treatment are performed on the container. Consideration received and allocated to the transportation and treatment performance obligation is recorded as a contract liability until the services are performed. Through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the return transportation and treatment element is recognized at the point of sale. Furthermore, the current and long-term portions of amounts historically referred to deferred revenues (shown as Contract Liability on the condensed consolidated balance sheets) are determined through regression analysis and historical trends. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The VMI program includes terms that meet the “bill and hold” criteria and as such are recognized when the order is placed, title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse for the customer. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Without Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current contract asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">741</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term contract asset</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,896</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current contract liability</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,801</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,803</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term contract liability</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,213</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated Deficit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,649</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(353</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,002</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(353</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1): Prior period contract liabilities were referred to as deferred revenue.</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As Reported</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Without Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,293</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,941</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,350</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,039</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized revenue of </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> that was included in the current contract liability at July 1, 2018. The estimated timing of recognition of amounts included at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are as follows: for the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">September 30,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> - contract asset of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and contract liability of </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and for the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">September 30,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;"> - contract asset of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and contract liability of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">. The contract asset is related to VMI service agreements within the mailbacks contract type category when the revenue recognition exceeds the amount of consideration the Company was entitled to at the point in time of satisfying the performance obligation associated with the sale of the compliance and container system. The contract liability is related to the mailbacks and unused medications contract type categories in which cash consideration exceeds the transaction price allocated to completed performance obligations. Incremental costs to obtain contracts that are deemed to be recoverable under the new accounting guidance, primarily related to the payment of sales incentives for contracts in the route-based pickup service category, are capitalized as contract costs and included in prepaids and other current assets in the amount of </font><font style="font-family:inherit;font-size:10pt;">$13 thousand</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. The amortization of capitalized sales incentives, which is included in selling, general and administrative expense, totaled </font><font style="font-family:inherit;font-size:10pt;">$1 thousand</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. A valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The Company's deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> reflects the accumulated tax expense related to the effect of indefinite lived assets, such as goodwill, which cannot be used as a source of future taxable income in evaluating the need for a valuation against deferred tax assets offset by realizable deferred tax assets associated with alternative minimum tax credits of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Accounts Receivable</font><font style="font-family:inherit;font-size:10pt;">: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Goodwill and Other Identifiable Intangible Assets:</font><font style="font-family:inherit;font-size:10pt;"> Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment during the prior year ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and there have been no triggering events since that date that would warrant further impairment testing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stock-Based Compensation</font><font style="font-family:inherit;font-size:10pt;">: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fair Value of Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">: The Company considers the fair value of all financial instruments, including cash, accounts receivable and accounts payable to approximate their carrying values at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Reclassification of Prior Year Presentation in the Consolidated Statements of Cash Flows:</font><font style="font-family:inherit;font-size:10pt;"> Certain prior year amounts have been reclassified for consistency with the current year presentation in the Consolidated Statements of Cash Flows. The change in classification does not affect previously reported cash flows from operating activities, investing activities or financing activities in the Consolidated Statements of Cash Flows.</font></div></div>

EX-101.SCH 7 smed-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - EQUITY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 2409401 - Disclosure - EQUITY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - ORGANIZATION AND BACKGROUND link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - ORGANIZATION AND BACKGROUND (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - RECENTLY ISSUED ACCOUNTING STANDARDS link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation Period (Details) link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2403406 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of Impact of New Accounting Guidance (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of Revenue by Solution (Details) link:presentationLink link:calculationLink link:definitionLink 2303302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 smed-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 smed-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 smed-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounting Policies [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Adjustments Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Balance Without Adoption Calculated under Revenue Guidance in Effect before Topic 606 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Current contract assets Contract with Customer, Asset, Net, Current Prepaid and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Long-term contract asset Contract with Customer, Asset, Net, Noncurrent Total assets Assets Current contract liability Contract with Customer, Liability, Current Total current liabilities Liabilities, Current Long-term contract liability Contract with Customer, Liability, Noncurrent Total Liabilities Liabilities Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders' equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders' equity Liabilities and Equity Revenues Revenue from Contract with Customer, Including Assessed Tax Cost of revenues Cost of Goods and Services Sold Gross profits Gross Profit Selling, general and administrative Selling, General and Administrative Expense Operating income Operating Income (Loss) Net income Net Income (Loss) Attributable to Parent Stockholders' Equity Note [Abstract] EQUITY TRANSACTIONS Stockholders' Equity Note Disclosure [Text Block] Exercises of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Compensation expense related to non-vested awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average period Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Shares of common stock issued for third-party lease agreement (in shares) Stock Issued During Period, Shares, Issued for Services Price per share (in dollars per share) Shares Issued, Price Per Share Non-cash lease expense Operating Leases, Rent Expense Debt Disclosure [Abstract] Schedule of long-term debt Schedule of Long-term Debt Instruments [Table Text Block] Schedule of payments due on long-term debt Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer relationships Customer Relationships [Member] Permits Construction Permits [Member] Patents Patents [Member] Trade name Trade Names [Member] Non-compete Noncompete Agreements [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Estimated Useful Lives Finite-Lived Intangible Asset, Useful Life Original Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Total Finite-Lived Intangible Assets, Net Intangible assets, amortization expense Amortization of Intangible Assets Changes in goodwill Goodwill, Period Increase (Decrease) Future amortization of intangible assets [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2019 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Estimated timing of recognition, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Line of Credit Facility [Table] Line of Credit Facility [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Credit Agreement Credit Agreement [Member] A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars. Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Working Capital Working Capital [Member] Working capital is money available to a company for day-to-day operations. Letter of Credit Letter of Credit [Member] Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Term Loan Term Loan [Member] A term loan is a monetary loan that is repaid in regular payments over a set period of time. Term loans usually last between one and ten years. Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Performance bonds Surety Bond [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Maturity extension period Debt Instrument, Term Extension Debt Instrument, Term Extension Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Percentage of eligible accounts receivable considered for borrowing base Percentage of eligible accounts receivable considered for borrowing base Percentage of eligible accounts receivable considered for borrowing base as defined in the credit agreement. Percentage of eligible inventory considered for borrowing base Percentage of eligible inventory considered for borrowing base Percentage of eligible inventory considered for borrowing base as defined in the credit agreement. Borrowing base, monetary benchmark Borrowing Base, Monetary Benchmark For Percentage Of Eligible Accounts Borrowing Base, Monetary Benchmark For Percentage Of Eligible Accounts Percentage of portion allocated to acquisition purchase price Percentage of Portion Allocated to Acquisition Purchase Price Maximum borrowing limit percentage under line of credit facility as per the terms of the credit agreement. Maturity period Debt Instrument, Term Basis spread of variable rate Debt Instrument, Basis Spread on Variable Rate Debt instrument, term of variable rate Debt Instrument, Term of Variable Rate Term of interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index. Interest rate Line of Credit Facility, Interest Rate at Period End Unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Amount outstanding Long-term Line of Credit Debt cash flow leverage ratio Debt Cash Flow Leverage Ratio Ratio used to determine cash flows leverage tiers of the company. Debt service coverage ratio Debt Service Coverage Ratio Ratio used by bank loan officers in determining income property loans. Performance bonds outstanding, financial assurance Guarantor Obligations, Maximum Exposure, Undiscounted Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Stock-Based Compensation Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Statement of Financial Position [Abstract] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock, shares repurchased (in shares) Treasury Stock, Shares Earnings Per Share [Abstract] Schedule of Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] STOCK-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND BACKGROUND Nature of Operations [Text Block] NOTES PAYABLE AND LONG-TERM DEBT Debt Disclosure [Text Block] EARNINGS PER SHARE Earnings Per Share [Text Block] Summary of Revenue by Solution Disaggregation of Revenue [Table Text Block] Schedule of Impact of New Accounting Guidance New Accounting Pronouncements and Changes in Accounting Principles [Text Block] RECENTLY ISSUED ACCOUNTING STANDARDS Description of New Accounting Pronouncements Not yet Adopted [Text Block] Net income, as reported Weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Effect of dilutive stock options (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Weighted average diluted common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Net income per common share Earnings Per Share, Basic and Diluted [Abstract] Basic and Diluted (in dollars per share) Earnings Per Share, Basic and Diluted Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Accounts Receivable Receivables, Policy [Policy Text Block] Goodwill and Other Identifiable Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Stock-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Reclassifications of Prior Year Presentation in the Consolidated Statements of Cash Flows Reclassification, Policy [Policy Text Block] Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of revenues Cost of Sales [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Stock-based compensation Allocated Share-based Compensation Expense Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Treasury Stock Treasury Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings [Member] Statement [Line Items] Statement [Line Items] Balance at beginning (in shares) Shares, Issued Balances at beginning Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of common shares for lease (in shares) Issuance of common shares for lease Stock Issued During Period, Value, Issued for Services Issuance of restricted stock (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Issuance of restricted stock Stock Issued During Period, Value, Restricted Stock Award, Gross Cumulative effect of new accounting standard (Note 3) Cumulative Effect of New Accounting Principle in Period of Adoption Net income (loss) Balance at end (in shares) Balances at end Inventory Disclosure [Abstract] INVENTORY Inventory Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Interest rate Debt Instrument, Interest Rate, Stated Percentage Monthly payments Debt Instrument, Periodic Payment Total debt Long-term Debt Less: current portion Long-term Debt, Current Maturities Long-term debt, net of current portion Long-term Debt, Excluding Current Maturities BASIS OF PRESENTATION Business Description and Basis of Presentation [Text Block] Income Statement [Abstract] REVENUES GROSS PROFIT Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction OPERATING INCOME OTHER INCOME (EXPENSE) Nonoperating Income (Expense) [Abstract] Interest income Investment Income, Interest Interest expense Interest Expense TOTAL OTHER EXPENSE Nonoperating Income (Expense) INCOME BEFORE INCOME TAXES Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest INCOME TAX EXPENSE Income Tax Expense (Benefit), Continuing Operations [Abstract] Current Current Income Tax Expense (Benefit) Deferred Deferred Income Tax Expense (Benefit) TOTAL INCOME TAX EXPENSE Income Tax Expense (Benefit) NET INCOME NET INCOME PER COMMON SHARE - Basic and Diluted EX-101.PRE 11 smed-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Sep. 30, 2018	Oct. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	SHARPS COMPLIANCE CORP
Entity Central Index Key	0000898770
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding		16,082,021
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2018

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
CURRENT ASSETS
Cash	$ 5,149	$ 5,155
Accounts receivable, net of allowance for doubtful accounts of $110 and $102, respectively	6,800	6,370
Inventory	4,144	3,986
Contract asset	278	0
Prepaid and other current assets	741	739
TOTAL CURRENT ASSETS	17,112	16,250
PROPERTY, PLANT AND EQUIPMENT, net	6,310	6,572
LONG-TERM CONTRACT ASSET, net of current portion	60	0
OTHER ASSETS	143	149
GOODWILL	6,735	6,735
INTANGIBLE ASSETS, net	3,536	3,525
TOTAL ASSETS	33,896	33,231
CURRENT LIABILITIES
Accounts payable	1,894	1,500
Accrued liabilities	2,042	2,061
Current maturities of long-term debt	517	537
Contract Liabilities	1,801	1,894
TOTAL CURRENT LIABILITIES	6,254	5,992
LONG-TERM CONTRACT LIABILITY, net of current portion	462	470
OTHER LONG-TERM LIABILITIES	137	130
LONG-TERM DEFERRED TAX LIABILITY	25	0
LONG-TERM DEBT, net of current portion	1,335	1,465
TOTAL LIABILITIES	8,213	8,057
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,377,636 shares issued and 16,082,021 shares outstanding	164	164
Treasury stock, at cost, 295,615 shares repurchased	(1,554)	(1,554)
Additional paid-in capital	28,722	28,621
Accumulated deficit	(1,649)	(2,057)
TOTAL STOCKHOLDERS' EQUITY	25,683	25,174
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 33,896	$ 33,231

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 110	$ 102
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	16,377,636	16,377,636
Common stock, shares outstanding (in shares)	16,082,021	16,082,021
Treasury stock, shares repurchased (in shares)	295,615	295,615

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
REVENUES	$ 10,293	$ 9,683
Cost of revenues	6,941	6,655
GROSS PROFIT	3,352	3,028
Selling, general and administrative	3,026	2,725
Depreciation and amortization	201	202
OPERATING INCOME	125	101
OTHER INCOME (EXPENSE)
Interest income	5	5
Interest expense	(23)	(24)
TOTAL OTHER EXPENSE	(18)	(19)
INCOME BEFORE INCOME TAXES	107	82
INCOME TAX EXPENSE
Current	4	5
Deferred	33	2
TOTAL INCOME TAX EXPENSE	37	7
NET INCOME	$ 70	$ 75
NET INCOME PER COMMON SHARE - Basic and Diluted
Basic and Diluted (in dollars per share)	$ 0.00	$ 0.00
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE:
Basic (in shares)	16,082	16,008
Diluted (in shares)	16,089	16,093

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at beginning (in shares) at Jun. 30, 2017		16,304,027	295,615
Balances at beginning at Jun. 30, 2017	$ 25,287	$ 163	$ (1,554)	$ 28,063	$ (1,385)
Stock-based compensation	476			476
Issuance of common shares for lease (in shares)		20,617
Issuance of common shares for lease	83	$ 0		83
Issuance of restricted stock (in shares)		52,992
Issuance of restricted stock	0	$ 1		(1)
Net income (loss)	(672)				(672)
Balance at end (in shares) at Jun. 30, 2018		16,377,636	295,615
Balances at end at Jun. 30, 2018	25,174	$ 164	$ (1,554)	28,621	(2,057)
Cumulative effect of new accounting standard (Note 3)	338				338
Stock-based compensation	$ 101			101
Issuance of common shares for lease (in shares)	20,617
Net income (loss)	$ 70				70
Balance at end (in shares) at Sep. 30, 2018		16,377,636	295,615
Balances at end at Sep. 30, 2018	$ 25,683	$ 164	$ (1,554)	$ 28,722	$ (1,649)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 70	$ 75	$ (672)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	391	390
Bad debt expense	17	5
Non-cash lease expense	12	0
Loss on disposal of property, plant and equipment	0	(2)
Stock-based compensation expense	101	121
Deferred tax expense	33	2
Changes in operating assets and liabilities:
Accounts receivable	(447)	269
Inventory	(39)	(72)
Prepaid and other assets	(16)	124
Accounts payable and accrued liabilities	365	(29)
Contract liability	(101)	25
NET CASH PROVIDED BY OPERATING ACTIVITIES	386	908
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(79)	(235)
Cash proceeds from sale of property, plant and equipment	0	3
Additions to intangible assets	(163)	(41)
NET CASH USED IN INVESTING ACTIVITIES	(242)	(273)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of long-term debt	(150)	(150)
NET CASH USED IN FINANCING ACTIVITIES	(150)	(150)
NET (DECREASE) INCREASE IN CASH	(6)	485
CASH, beginning of period	5,155	4,675	4,675
CASH, end of period	5,149	5,160	$ 5,155
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	8	3
Interest paid on long-term debt	24	17
NON-CASH INVESTING ACTIVITIES:
Transfer of equipment to inventory	119	69
Property, plant and equipment financed through accounts payable	$ 17	$ 21

XML 18 R7.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND BACKGROUND	3 Months Ended
ORGANIZATION AND BACKGROUND	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BACKGROUND	ORGANIZATION AND BACKGROUND Organization: The accompanying unaudited condensed consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation. Business: Sharps is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System^®), TakeAway Medication Recovery System™, MedSafe^®, TakeAway Recycle System™,ComplianceTRAC^SM, SharpsTracer^®, Sharps Secure^®Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System. The Company also offers its route-based pick-up services in a twenty-four (24) state region of the South, Southeast and Northeast portions of the United States.

XML 19 R8.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under generally accepted accounting principles in the United States of America ("GAAP") for complete financial statements. Additionally, the preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of September 30, 2018, the results of its operations for the three months ended September 30, 2018 and 2017, cash flows for the three months ended September 30, 2018 and 2017 and stockholders’ equity for the three months ended September 30, 2018. The results of operations for the three months ended September 30, 2018 are not necessarily indicative of the results to be expected for the entire fiscal year ending June 30, 2019. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended June 30, 2018.

XML 20 R9.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES


•	The transportation and treatment performance obligations related to the mail back and unused medication solutions, which were historically accounted for as separate performance obligations, will be accounted for as a single performance obligation under the new revenue recognition guidance. The impact of this was not material.


•	Certain costs associated with obtaining long-term contracts with customers will be capitalized and amortized over the expected economic life of the contract in future periods. The impact of this was not material.


•	The new guidance changed the timing of revenue recognition on certain of the Company’s vendor managed inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.

•

The Company made a number of practical expedient elections related to the new accounting guidance, including: (i) right to invoice practical expedient that allows revenue for route-based pickup services to be recognized in the amount to which the Company has a right to invoice over time; (ii) sales and use taxes have been excluded from the transaction price; (iii) for incremental costs to obtain a contract that would be recognized over one year or less, the Company expenses those costs as incurred; and (iv) at the implementation date, new guidance was applied only to contracts that were not completed as of the date of initial application.

The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (in thousands):



	Three-Months Ended September 30,
	2018		% Total		2017⁽²⁾		% Total
REVENUES BY SOLUTION:
Mailbacks	$	5,607	54.5	%	$	5,465	56.4	%
Route-based pickup services	2,128		20.7	%	1,761		18.2	%
Unused medications	1,639		15.9	%	1,172		12.1	%
Third party treatment services	102		1.0	%	434		4.5	%
Other ⁽¹⁾	817		7.9	%	851		8.8	%
Total revenues	$	10,293	100.0	%	$	9,683	100.0	%


(1)	The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.


(2)	Certain prior year amounts have been reclassified to conform to current year presentation.

The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of September 30, 2018 was as follows (in thousands):



	September 30, 2018
	As Reported			Adjustments			Balance Without Adoption
Current contract asset	$	278		$	(278	)	$	—
Prepaid and other current assets	741			(13		)	728
Total current assets	17,112			(291		)	16,821
Long-term contract asset	60			(60		)	—
Total assets	33,896			(351		)	33,545
Current contract liability⁽¹⁾	1,801			2			1,803
Total current liabilities	6,254			2			6,256
Long-term contract liability⁽¹⁾	462			—			462
Total Liabilities	8,213			2			8,215
Accumulated Deficit	(1,649		)	(353		)	(2,002		)
Total stockholders' equity	25,683			(353		)	25,330
Total liabilities and stockholders' equity	33,896			(351		)	33,545

(1): Prior period contract liabilities were referred to as deferred revenue.

The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the three months ended September 30, 2018 was as follows (in thousands):



	September 30, 2018
	As Reported		Adjustments			Balance Without Adoption
Revenues	$	10,293	$	35		$	10,328
Cost of revenues	6,941		37			6,978
Gross profits	3,352		(2		)	3,350
Selling, general and administrative	3,026		13			3,039
Operating income	125		(15		)	110
Net income	70		(15		)	55

During the three months ended September 30, 2018, the Company recognized revenue of $0.9 million that was included in the current contract liability at July 1, 2018. The estimated timing of recognition of amounts included at September 30, 2018 are as follows: for the twelve months ended September 30, 2019 - contract asset of $0.3 million and contract liability of $1.8 million and for the twelve months ended September 30, 2020 - contract asset of $0.1 million and contract liability of $0.5 million. The contract asset is related to VMI service agreements within the mailbacks contract type category when the revenue recognition exceeds the amount of consideration the Company was entitled to at the point in time of satisfying the performance obligation associated with the sale of the compliance and container system. The contract liability is related to the mailbacks and unused medications contract type categories in which cash consideration exceeds the transaction price allocated to completed performance obligations. Incremental costs to obtain contracts that are deemed to be recoverable under the new accounting guidance, primarily related to the payment of sales incentives for contracts in the route-based pickup service category, are capitalized as contract costs and included in prepaids and other current assets in the amount of $13 thousand as of September 30, 2018. The amortization of capitalized sales incentives, which is included in selling, general and administrative expense, totaled $1 thousand for the three months ended September 30, 2018.

XML 21 R10.htm IDEA: XBRL DOCUMENT

RECENTLY ISSUED ACCOUNTING STANDARDS	3 Months Ended
RECENTLY ISSUED ACCOUNTING STANDARDS	Sep. 30, 2018
Accounting Policies [Abstract]
RECENTLY ISSUED ACCOUNTING STANDARDS	RECENTLY ISSUED ACCOUNTING STANDARDS In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

XML 22 R11.htm IDEA: XBRL DOCUMENT

INCOME TAXES	3 Months Ended
INCOME TAXES	Sep. 30, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s effective tax rate for the three months ended September 30, 2018 was 34.6% reflecting primarily deferred tax expense related to the effect of indefinite lived assets, such as goodwill, which cannot be used as a source of future taxable income in evaluating the need for a valuation allowance against deferred tax assets as well as estimated state income tax. For the three months ended September 30, 2018, the Company recorded total income tax expense of $37 thousand, consisting of estimated federal income tax expense of $33 thousand and estimated state income tax expense of $4 thousand. For the three months ended September 30, 2017, the Company recorded a total income tax expense of $7 thousand, consisting primarily of state income taxes.

XML 23 R12.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT

3 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

NOTES PAYABLE AND LONG-TERM DEBT

At September 30, 2018, long-term debt consisted of the following (in thousands):



Term loan, bearing interest at 4.25%, monthly payments of $43; maturing March 2022.	$	1,852
Less: current portion	517
Long-term debt, net of current portion	$	1,335

Payments due on long-term debt during each of the five years subsequent to September 30, 2018 are as follows (in thousands):



Twelve Months Ending September 30,
2019	$	517
2020	517
2021	517
2022	301
	$	1,852

XML 24 R13.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION

3 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION



	Three-Months Ended September 30,
	2018			2017
Stock-based compensation expense included in:
Cost of revenues	$	(2	)	$	14
Selling, general and administrative	103			107
Total	$	101		$	121

XML 25 R14.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE

3 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

EARNINGS PER SHARE

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):



	Three-Months Ended September 30,
	2018		2017
Net income, as reported	$	70	$	75

Weighted average common shares outstanding	16,082		16,008
Effect of dilutive stock options	7		85
Weighted average diluted common shares outstanding	16,089		16,093

Net income per common share
Basic and diluted	$	0.00	$	0.00

Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive	851		231

XML 26 R15.htm IDEA: XBRL DOCUMENT

EQUITY TRANSACTIONS	3 Months Ended
EQUITY TRANSACTIONS	Sep. 30, 2018
Stockholders' Equity Note [Abstract]
EQUITY TRANSACTIONS	EQUITY TRANSACTIONS During the three months ended September 30, 2018 and 2017, there were no exercises of stock options to purchase shares of the Company's common stock. As of September 30, 2018, there was $0.2 million of stock compensation expense related to non-vested awards which is expected to be recognized over a weighted average period of 2.4 years. During the twelve months ended June 30, 2018, the Company issued 20,617 shares of common stock as a portion of consideration for a third-party lease agreement. The shares were issued at $4.00 per share based on the closing price on the date of grant. This issuance was exempt from registration pursuant to Section 4(a)(2) of the Securities Act. Non-cash expense recorded during the three months ended September 30, 2018 was $12 thousand. The remaining cost will be amortized over the life of the lease and is included in Prepaid and Other Current Assets or Other Assets on the balance sheet.

XML 27 R16.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS

3 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

At September 30, 2018 and June 30, 2018, intangible assets consisted of the following (in thousands):



		September 30, 2018							June 30, 2018
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount
Customer relationships	7 years	$	3,007	$	(1,026	)	$	1,981	$	3,007	$	(919	)	$	2,088
Permits	6 - 15 years	1,610		(416		)	1,194		1,459		(390		)	1,069
Patents	5 - 17 years	395		(281		)	114		383		(278		)	105
Trade name	7 years	270		(87		)	183		270		(77		)	193
Non-compete	5 years	117		(53		)	64		117		(47		)	70
Total intangible assets, net		$	5,399	$	(1,863	)	$	3,536	$	5,236	$	(1,711	)	$	3,525

During both the three months ended September 30, 2018 and 2017, amortization expense was $0.2 million. There have been no changes in the carrying amount of goodwill since June 30, 2018.

As of September 30, 2018, future amortization of intangible assets is as follows (in thousands):



Twelve Months Ending September 30,
2019	$	643
2020	634
2021	627
2022	599
2023	441
Thereafter	592
	$	3,536

XML 28 R17.htm IDEA: XBRL DOCUMENT

INVENTORY

3 Months Ended

Sep. 30, 2018

Inventory Disclosure [Abstract]

INVENTORY

The components of inventory are as follows (in thousands):



	September 30, 2018		June 30, 2018
Raw materials	$	1,419	$	1,323
Finished goods	2,725		2,663
Total	$	4,144	$	3,986

XML 29 R18.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Revenue Recognition


•	The transportation and treatment performance obligations related to the mail back and unused medication solutions, which were historically accounted for as separate performance obligations, will be accounted for as a single performance obligation under the new revenue recognition guidance. The impact of this was not material.


•	Certain costs associated with obtaining long-term contracts with customers will be capitalized and amortized over the expected economic life of the contract in future periods. The impact of this was not material.


•	The new guidance changed the timing of revenue recognition on certain of the Company’s vendor managed inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.

•

Income Taxes

Accounts Receivable

Goodwill and Other Identifiable Intangible Assets

Stock-Based Compensation

Fair Value of Financial Instruments

Reclassifications of Prior Year Presentation in the Consolidated Statements of Cash Flows

Recently Issued Accounting Standards

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References + Details

- Definition

Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.

+ References + Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Summary of Revenue by Solution

inventory contracts. This constituted a material portion of the cumulative effect noted above as under the new guidance, revenue recognition is no longer limited to the amounts that may be billed to the customer at the point in time in which performance obligations are satisfied.

•

Schedule of Impact of New Accounting Guidance

The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of September 30, 2018 was as follows (in thousands):



	September 30, 2018
	As Reported			Adjustments			Balance Without Adoption
Current contract asset	$	278		$	(278	)	$	—
Prepaid and other current assets	741			(13		)	728
Total current assets	17,112			(291		)	16,821
Long-term contract asset	60			(60		)	—
Total assets	33,896			(351		)	33,545
Current contract liability⁽¹⁾	1,801			2			1,803
Total current liabilities	6,254			2			6,256
Long-term contract liability⁽¹⁾	462			—			462
Total Liabilities	8,213			2			8,215
Accumulated Deficit	(1,649		)	(353		)	(2,002		)
Total stockholders' equity	25,683			(353		)	25,330
Total liabilities and stockholders' equity	33,896			(351		)	33,545

(1): Prior period contract liabilities were referred to as deferred revenue.

The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the three months ended September 30, 2018 was as follows (in thousands):



	September 30, 2018
	As Reported		Adjustments			Balance Without Adoption
Revenues	$	10,293	$	35		$	10,328
Cost of revenues	6,941		37			6,978
Gross profits	3,352		(2		)	3,350
Selling, general and administrative	3,026		13			3,039
Operating income	125		(15		)	110
Net income	70		(15		)	55

XML 31 R20.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT (Tables)

3 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Schedule of long-term debt

At September 30, 2018, long-term debt consisted of the following (in thousands):



Term loan, bearing interest at 4.25%, monthly payments of $43; maturing March 2022.	$	1,852
Less: current portion	517
Long-term debt, net of current portion	$	1,335

Schedule of payments due on long-term debt

Payments due on long-term debt during each of the five years subsequent to September 30, 2018 are as follows (in thousands):



Twelve Months Ending September 30,
2019	$	517
2020	517
2021	517
2022	301
	$	1,852

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

XML 32 R21.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Stock-Based Compensation

During the three months ended September 30, 2018 and 2017, stock-based compensation amounts are as follows (in thousands):



	Three-Months Ended September 30,
	2018			2017
Stock-based compensation expense included in:
Cost of revenues	$	(2	)	$	14
Selling, general and administrative	103			107
Total	$	101		$	121

XML 33 R22.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE (Tables)

3 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):



	Three-Months Ended September 30,
	2018		2017
Net income, as reported	$	70	$	75

Weighted average common shares outstanding	16,082		16,008
Effect of dilutive stock options	7		85
Weighted average diluted common shares outstanding	16,089		16,093

Net income per common share
Basic and diluted	$	0.00	$	0.00

Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive	851		231

XML 34 R23.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Tables)

3 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

At September 30, 2018 and June 30, 2018, intangible assets consisted of the following (in thousands):



		September 30, 2018							June 30, 2018
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount
Customer relationships	7 years	$	3,007	$	(1,026	)	$	1,981	$	3,007	$	(919	)	$	2,088
Permits	6 - 15 years	1,610		(416		)	1,194		1,459		(390		)	1,069
Patents	5 - 17 years	395		(281		)	114		383		(278		)	105
Trade name	7 years	270		(87		)	183		270		(77		)	193
Non-compete	5 years	117		(53		)	64		117		(47		)	70
Total intangible assets, net		$	5,399	$	(1,863	)	$	3,536	$	5,236	$	(1,711	)	$	3,525

Schedule of future amortization of intangible assets

As of September 30, 2018, future amortization of intangible assets is as follows (in thousands):



Twelve Months Ending September 30,
2019	$	643
2020	634
2021	627
2022	599
2023	441
Thereafter	592
	$	3,536

XML 35 R24.htm IDEA: XBRL DOCUMENT

INVENTORY (Tables)

3 Months Ended

Sep. 30, 2018

Inventory Disclosure [Abstract]

Schedule of Inventory

The components of inventory are as follows (in thousands):



	September 30, 2018		June 30, 2018
Raw materials	$	1,419	$	1,323
Finished goods	2,725		2,663
Total	$	4,144	$	3,986

XML 36 R25.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND BACKGROUND (Details)	3 Months Ended
ORGANIZATION AND BACKGROUND (Details)	Sep. 30, 2018 state_region
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of route-based pick-up service in state region	24

XML 37 R26.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Jul. 01, 2018	Jun. 30, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accumulated deficit	$ (1,649,000)		$ (2,057,000)
Stockholders' equity	25,683,000		25,174,000		$ 25,287,000
Cumulative effect of new accounting standard			338,000
Revenue recorded from inventory builds	400,000	$ 1,000,000
Solutions sold that were held in vendor managed inventory	1,700,000		2,100,000
Revenue recognized	900,000
Current contract assets	278,000		0
Deferred contract assets	60,000		0
Current contract liabilities	1,801,000		1,894,000
Deferred contract liabilities	462,000		470,000
Capitalized contract costs	13,000
Amortization of capitalized sales incentives	1,000
Deferred tax liability related to effect of indefinite lived assets	300,000
Deferred tax assets associated with alternative minimum tax credits	200,000
Goodwill impairment			0
Adjustments \| Accounting Standards Update 2014-09
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accumulated deficit	(353,000)			$ 300,000
Stockholders' equity	(353,000)			300,000
Contract assets				$ 300,000
Current contract assets	(278,000)
Deferred contract assets	(60,000)
Current contract liabilities	2,000
Deferred contract liabilities	0
Accumulated Deficit
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	$ (1,649,000)		(2,057,000)		$ (1,385,000)
Cumulative effect of new accounting standard			$ 338,000

XML 38 R27.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Summary of Revenue by Solution (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Disaggregation of Revenue [Line Items]
Total revenues	$ 10,293	$ 9,683
Revenue percentage	100.00%	100.00%
Mailbacks
Disaggregation of Revenue [Line Items]
Total revenues	$ 5,607	$ 5,465
Revenue percentage	54.50%	56.40%
Route-based pickup services
Disaggregation of Revenue [Line Items]
Total revenues	$ 2,128	$ 1,761
Revenue percentage	20.70%	18.20%
Unused medications
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,639	$ 1,172
Revenue percentage	15.90%	12.10%
Third party treatment services
Disaggregation of Revenue [Line Items]
Total revenues	$ 102	$ 434
Revenue percentage	1.00%	4.50%
Other
Disaggregation of Revenue [Line Items]
Total revenues	$ 817	$ 851
Revenue percentage	7.90%	8.80%

XML 39 R28.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation Period (Details)	Sep. 30, 2018
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated timing of recognition, period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated timing of recognition, period	1 year

XML 40 R29.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES - Summary of Impact of New Accounting Guidance (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Jul. 01, 2018	Jun. 30, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Current contract assets	$ 278		$ 0
Prepaid and other current assets	741		739
Total current assets	17,112		16,250
Long-term contract asset	60		0
Total assets	33,896		33,231
Current contract liability	1,801		1,894
Total current liabilities	6,254		5,992
Long-term contract liability	462		470
Total Liabilities	8,213		8,057
Accumulated deficit	(1,649)		(2,057)
Total stockholders' equity	25,683		25,174		$ 25,287
Total liabilities and stockholders' equity	33,896		33,231
Revenues	10,293	$ 9,683
Cost of revenues	6,941	6,655
Gross profits	3,352	3,028
Selling, general and administrative	3,026	2,725
Operating income	125	101
Net income	70	$ 75	$ (672)
Balance Without Adoption
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Current contract assets	0
Prepaid and other current assets	728
Total current assets	16,821
Long-term contract asset	0
Total assets	33,545
Current contract liability	1,803
Total current liabilities	6,256
Long-term contract liability	462
Total Liabilities	8,215
Accumulated deficit	(2,002)
Total stockholders' equity	25,330
Total liabilities and stockholders' equity	33,545
Revenues	10,328
Cost of revenues	6,978
Gross profits	3,350
Selling, general and administrative	3,039
Operating income	110
Net income	55
Accounting Standards Update 2014-09 \| Adjustments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Current contract assets	(278)
Prepaid and other current assets	(13)
Total current assets	(291)
Long-term contract asset	(60)
Total assets	(351)
Current contract liability	2
Total current liabilities	2
Long-term contract liability	0
Total Liabilities	2
Accumulated deficit	(353)			$ 300
Total stockholders' equity	(353)			$ 300
Total liabilities and stockholders' equity	(351)
Revenues	35
Cost of revenues	37
Gross profits	(2)
Selling, general and administrative	13
Operating income	(15)
Net income	$ (15)

XML 41 R30.htm IDEA: XBRL DOCUMENT

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended
INCOME TAXES (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Effective income tax rate	34.60%
Income tax expense	$ 37	$ 7
Federal income tax expense	33
State income tax expense	$ 4

XML 42 R31.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details)	Jun. 29, 2018 USD ($)	Sep. 30, 2018 USD ($)
Performance bonds
Line of Credit Facility [Line Items]
Performance bonds outstanding, financial assurance		$ 1,000,000.0
Credit Agreement
Line of Credit Facility [Line Items]
Maturity extension period	2 years
Maximum borrowing capacity	$ 14,000,000.0
Percentage of eligible accounts receivable considered for borrowing base	80.00%
Percentage of eligible inventory considered for borrowing base	50.00%
Borrowing base, monetary benchmark	$ 3,000,000
Basis spread of variable rate	0.00%
Interest rate		4.63%
Unused capacity, commitment fee percentage	0.25%
Remaining borrowing capacity		$ 12,100,000
Credit Agreement \| Minimum
Line of Credit Facility [Line Items]
Debt service coverage ratio	1.15
Credit Agreement \| Maximum
Line of Credit Facility [Line Items]
Debt cash flow leverage ratio	3.0
Credit Agreement \| Term Loan
Line of Credit Facility [Line Items]
Maturity period	5 years
Credit Agreement \| Working Capital
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 6,000,000.0
Remaining borrowing capacity		6,000,000
Credit Agreement \| Letter of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	2,000,000.0
Amount outstanding		40,000
Credit Agreement \| Acquisitions
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 8,000,000.0
Percentage of portion allocated to acquisition purchase price	75.00%
Remaining borrowing capacity		$ 6,100,000
Credit Agreement \| LIBOR
Line of Credit Facility [Line Items]
Basis spread of variable rate	2.50%
Debt instrument, term of variable rate	1 month
Credit Agreement \| LIBOR \| Maximum
Line of Credit Facility [Line Items]
Basis spread of variable rate	3.00%

XML 43 R32.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Jun. 30, 2018
Debt Instrument [Line Items]
Less: current portion	$ 517	$ 537
Long-term debt, net of current portion	$ 1,335	$ 1,465
Credit Agreement \| Term Loan
Debt Instrument [Line Items]
Interest rate	4.25%
Monthly payments	$ 43
Total debt	1,852
Less: current portion	517
Long-term debt, net of current portion	$ 1,335

XML 44 R33.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) - Term Loan - Credit Agreement $ in Thousands	Sep. 30, 2018 USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
2019	$ 517
2020	517
2021	517
2022	301
Total debt	$ 1,852

XML 45 R34.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	3 Months Ended
STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 101	$ 121
Cost of revenues
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	(2)	14
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 103	$ 107

XML 46 R35.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018
Earnings Per Share [Abstract]
Net income, as reported	$ 70	$ 75	$ (672)
Weighted average common shares outstanding (in shares)	16,082	16,008
Effect of dilutive stock options (in shares)	7	85
Weighted average diluted common shares outstanding (in shares)	16,089	16,093
Net income per common share
Basic and Diluted (in dollars per share)	$ 0.00	$ 0.00
Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive (in shares)	851	231

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 47 R36.htm IDEA: XBRL DOCUMENT

EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Stockholders' Equity Note [Abstract]
Exercises of stock options (in shares)	0	0
Compensation expense related to non-vested awards	$ 200
Weighted average period	2 years 4 months 24 days
Shares of common stock issued for third-party lease agreement (in shares)	20,617
Price per share (in dollars per share)	$ 4
Non-cash lease expense	$ 12	$ 0

XML 48 R37.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018
Finite-Lived Intangible Assets [Line Items]
Original Amount	$ 5,399,000		$ 5,236,000
Accumulated Amortization	(1,863,000)		(1,711,000)
Total	3,536,000		3,525,000
Intangible assets, amortization expense	200,000	$ 200,000
Changes in goodwill	0
Future amortization of intangible assets [Abstract]
2019	643,000
2020	634,000
2021	627,000
2022	599,000
2023	441,000
Thereafter	592,000
Total	$ 3,536,000		3,525,000
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	7 years
Original Amount	$ 3,007,000		3,007,000
Accumulated Amortization	(1,026,000)		(919,000)
Total	1,981,000		2,088,000
Future amortization of intangible assets [Abstract]
Total	1,981,000		2,088,000
Permits
Finite-Lived Intangible Assets [Line Items]
Original Amount	1,610,000		1,459,000
Accumulated Amortization	(416,000)		(390,000)
Total	1,194,000		1,069,000
Future amortization of intangible assets [Abstract]
Total	$ 1,194,000		1,069,000
Permits \| Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	6 years
Permits \| Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	15 years
Patents
Finite-Lived Intangible Assets [Line Items]
Original Amount	$ 395,000		383,000
Accumulated Amortization	(281,000)		(278,000)
Total	114,000		105,000
Future amortization of intangible assets [Abstract]
Total	$ 114,000		105,000
Patents \| Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	5 years
Patents \| Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	17 years
Trade name
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	7 years
Original Amount	$ 270,000		270,000
Accumulated Amortization	(87,000)		(77,000)
Total	183,000		193,000
Future amortization of intangible assets [Abstract]
Total	$ 183,000		193,000
Non-compete
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	5 years
Original Amount	$ 117,000		117,000
Accumulated Amortization	(53,000)		(47,000)
Total	64,000		70,000
Future amortization of intangible assets [Abstract]
Total	$ 64,000		$ 70,000

XML 49 R38.htm IDEA: XBRL DOCUMENT

INVENTORY (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Components of inventory [Abstract]
Raw materials	$ 1,419	$ 1,323
Finished goods	2,725	2,663
Total	$ 4,144	$ 3,986

EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 51 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 81 181 1 false 29 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://sharpsinc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://sharpsinc.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://sharpsinc.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://sharpsinc.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Sheet http://sharpsinc.com/role/CondensedConsolidatedStatementsOfStockholdersEquityUnaudited CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://sharpsinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 2101100 - Disclosure - ORGANIZATION AND BACKGROUND Sheet http://sharpsinc.com/role/OrganizationAndBackground ORGANIZATION AND BACKGROUND Notes 7 false false R8.htm 2102100 - Disclosure - BASIS OF PRESENTATION Sheet http://sharpsinc.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 8 false false R9.htm 2103100 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://sharpsinc.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 2104100 - Disclosure - RECENTLY ISSUED ACCOUNTING STANDARDS Sheet http://sharpsinc.com/role/RecentlyIssuedAccountingStandards RECENTLY ISSUED ACCOUNTING STANDARDS Notes 10 false false R11.htm 2105100 - Disclosure - INCOME TAXES Sheet http://sharpsinc.com/role/IncomeTaxes INCOME TAXES Notes 11 false false R12.htm 2106100 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT Notes http://sharpsinc.com/role/NotesPayableAndLongTermDebt NOTES PAYABLE AND LONG-TERM DEBT Notes 12 false false R13.htm 2107100 - Disclosure - STOCK-BASED COMPENSATION Sheet http://sharpsinc.com/role/StockBasedCompensation STOCK-BASED COMPENSATION Notes 13 false false R14.htm 2108100 - Disclosure - EARNINGS PER SHARE Sheet http://sharpsinc.com/role/EarningsPerShare EARNINGS PER SHARE Notes 14 false false R15.htm 2109100 - Disclosure - EQUITY TRANSACTIONS Sheet http://sharpsinc.com/role/EquityTransactions EQUITY TRANSACTIONS Notes 15 false false R16.htm 2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://sharpsinc.com/role/GoodwillAndIntangibleAssets GOODWILL AND INTANGIBLE ASSETS Notes 16 false false R17.htm 2111100 - Disclosure - INVENTORY Sheet http://sharpsinc.com/role/Inventory INVENTORY Notes 17 false false R18.htm 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://sharpsinc.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 2303302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://sharpsinc.com/role/SignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://sharpsinc.com/role/SignificantAccountingPolicies 19 false false R20.htm 2306301 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables) Notes http://sharpsinc.com/role/NotesPayableAndLongTermDebtTables NOTES PAYABLE AND LONG-TERM DEBT (Tables) Tables http://sharpsinc.com/role/NotesPayableAndLongTermDebt 20 false false R21.htm 2307301 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://sharpsinc.com/role/StockBasedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://sharpsinc.com/role/StockBasedCompensation 21 false false R22.htm 2308301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://sharpsinc.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://sharpsinc.com/role/EarningsPerShare 22 false false R23.htm 2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://sharpsinc.com/role/GoodwillAndIntangibleAssetsTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://sharpsinc.com/role/GoodwillAndIntangibleAssets 23 false false R24.htm 2311301 - Disclosure - INVENTORY (Tables) Sheet http://sharpsinc.com/role/InventoryTables INVENTORY (Tables) Tables http://sharpsinc.com/role/Inventory 24 false false R25.htm 2401401 - Disclosure - ORGANIZATION AND BACKGROUND (Details) Sheet http://sharpsinc.com/role/OrganizationAndBackgroundDetails ORGANIZATION AND BACKGROUND (Details) Details http://sharpsinc.com/role/OrganizationAndBackground 25 false false R26.htm 2403403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://sharpsinc.com/role/SignificantAccountingPoliciesNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 26 false false R27.htm 2403404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of Revenue by Solution (Details) Sheet http://sharpsinc.com/role/SignificantAccountingPoliciesSummaryOfRevenueBySolutionDetails SIGNIFICANT ACCOUNTING POLICIES - Summary of Revenue by Solution (Details) Details 27 false false R28.htm 2403405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation Period (Details) Sheet http://sharpsinc.com/role/SignificantAccountingPoliciesPerformanceObligationPeriodDetails SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation Period (Details) Details 28 false false R29.htm 2403406 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of Impact of New Accounting Guidance (Details) Sheet http://sharpsinc.com/role/SignificantAccountingPoliciesSummaryOfImpactOfNewAccountingGuidanceDetails SIGNIFICANT ACCOUNTING POLICIES - Summary of Impact of New Accounting Guidance (Details) Details 29 false false R30.htm 2405401 - Disclosure - INCOME TAXES (Details) Sheet http://sharpsinc.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://sharpsinc.com/role/IncomeTaxes 30 false false R31.htm 2406402 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) Notes http://sharpsinc.com/role/NotesPayableAndLongTermDebtNarrativeDetails NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) Details 31 false false R32.htm 2406403 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) Notes http://sharpsinc.com/role/NotesPayableAndLongTermDebtScheduleOfDebtInstrumentsDetails NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) Details 32 false false R33.htm 2406404 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) Notes http://sharpsinc.com/role/NotesPayableAndLongTermDebtScheduleOfPaymentsDueOnLongTermDebtDetails NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) Details 33 false false R34.htm 2407402 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://sharpsinc.com/role/StockBasedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://sharpsinc.com/role/StockBasedCompensationTables 34 false false R35.htm 2408402 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://sharpsinc.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://sharpsinc.com/role/EarningsPerShareTables 35 false false R36.htm 2409401 - Disclosure - EQUITY TRANSACTIONS (Details) Sheet http://sharpsinc.com/role/EquityTransactionsDetails EQUITY TRANSACTIONS (Details) Details http://sharpsinc.com/role/EquityTransactions 36 false false R37.htm 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) Sheet http://sharpsinc.com/role/GoodwillAndIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS (Details) Details http://sharpsinc.com/role/GoodwillAndIntangibleAssetsTables 37 false false R38.htm 2411402 - Disclosure - INVENTORY (Details) Sheet http://sharpsinc.com/role/InventoryDetails INVENTORY (Details) Details http://sharpsinc.com/role/InventoryTables 38 false false All Reports Book All Reports smed-20180930.xml smed-20180930.xsd smed-20180930_cal.xml smed-20180930_def.xml smed-20180930_lab.xml smed-20180930_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 56 0000898770-18-000040-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000898770-18-000040-xbrl.zip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end